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Abstract 
An elevation of CO2 concentration in the blood (hypercapnia) may occur as a result of poor alveolar 
gas exchange and is frequently detected in patients with respiratory diseases including those with 
acute respiratory distress syndrome (ARDS). Hypercapnia may be further exacerbated as a 
consequence of lung-protective mechanical ventilation with low tidal volumes, which is necessary 
in patients with ARDS. The vectorial Na+ transport across the alveolar epithelium mediated by the 
epithelial Na+ channel (ENaC) and the Na,K-ATPase provides the driving force for alveolar fluid 
clearance (AFC). Persistent alveolar edema is a hallmark of ARDS and can be attributed in part to 
impaired Na+ and fluid reabsorption, which leads to worse outcomes. Thus, the effects of 
hypercapnia on ENaC function in the alveolar epithelium and understanding of the signaling 
pathways that may via downregulation of ENaC impair edema clearance in hypercapnic patients 
with ARDS are of high clinical relevance.  
The current work describes the molecular mechanisms by which hypercapnia reduces cell surface 
expression of ENaC in alveolar epithelial cells (AECs) and thus impairs ENaC-driven 
transepithelial Na+ transport. We found that acute hypercapnia independently of pH (pCO2 ~120 
mmHg, pH 7.4 for 30 min) led to polyubiquitination of β-ENaC and subsequent endocytosis of the 
α/β-ENaC complex from the cell surface of primary rat ATII and human alveolar epithelial A549 
cells, as assessed by cell surface biotinylation and fluorescent microscopy. In contrast, hypercapnia 
altered neither mRNA nor intracellular levels of ENaC proteins, indicating that acutely elevated 
CO2 levels affect the trafficking of the channel rather than its transcription or degradation. 
Furthermore, our data established that hypercapnia by decreasing ENaC cell surface expression 
reduced both total (Isc) and amiloride-sensitive (Iamil-sens) Na
+ current in H441 human airway 
epithelial cells. Moreover, the hypercapnia-induced increase in polyubiquitination of β-ENaC and 
endocytosis of the α/β-ENaC complex were prevented by silencing the E3 ubiquitin ligase, Nedd4-
2. Co-immunoprecipitation studies confirmed the direct interaction of Nedd4-2 with the β-subunit 
of ENaC. Most importantly, the CO2-induced β-ENaC ubiquitination and α/β-ENaC retrieval from 
the cell surface were strongly dependent on the extracellular signal regulated kinase (ERK)1/2 that 
directly phosphorylated β-ENaC at the T615 residue. In line with these findings, transfection of 
A549 cells with a β-ENaC mutant lacking T615, normalized cell surface density of α/β-ENaC upon 
hypercapnic exposure. Activation of ERK1/2 caused subsequent activation of AMP-activated 
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protein kinase (AMPK) and c-Jun N-terminal kinase (JNK)1/2 that in turn phosphorylated Nedd4-
2 at the T899 residue. Replacement of the T899 residue by an alanine (T899A), which prevented 
JNK-mediated phosphorylation of Nedd4-2 significantly inhibited polyubiquitination of β-ENaC 
and improved cell surface expression of the α/β-ENaC complex upon CO2 treatment. Similarly, 
pharmacological inhibition of JNK rescued the abundance of ENaC at the cell surface upon 
hypercapnia. Additionally, chemical inhibition or genetic ablation of AMPK prevented the 
hypercapnia-induced β-ENaC polyubiquitination and internalization of the α/β-ENaC complex. A 
comparable reduction of ENaC endocytosis upon hypercapnia treatment was observed when an 
upstream kinase of AMPK, the Ca2+/calmodulin-dependent protein kinase kinase-β (CaMKK-β) 
was inhibited, confirming that the activation of AMPK was required for ENaC downregulation 
during acute hypercapnia. Thus, we describe a novel CO2-induced signaling pattern in alveolar 
epithelial cells, which by activation of the ERK/AMPK/JNK axis impairs cell surface expression 
and function of ENaC via promoting ubiquitination of β-ENaC and driving subsequent 
internalization of the channel. This signaling cascade may further impair alveolar fluid balance 
therefore leading to worse outcomes in patients with ARDS and thus also represent a potentially 
targetable pathway that might lead to discovery of novel therapies against alveolar edema in 
patients with hypercapnic respiratory failure. 
Zusammenfassung  
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Zusammenfassung 
Ein verminderter alveolärer Gasaustausch, welcher häufig bei Patienten mit 
Atemwegserkrankungen auftritt, einschließlich solchen mit einem akuten Lungenversagen (auch 
bekannt als acute respiratotry distress syndrome (ARDS)) führt oft zu einer Erhöhung der CO2 
Konzentration im Blut (Hyperkapnie). Hyperkapnie kann als Folge einer lungenschonenden 
Beatmung mit niedrigen Tidalvolumina, die bei Patienten mit ARDS notwendig ist, exazerbiert 
werden. Der vektorielle Na+-Transport über das Alveolarepithel, der durch den epithelialen Na+-
Kanal (ENaC) und die Na,K-ATPase vermittelt wird, liefert die treibende Kraft für die 
Alveolarfluid-Clearance (AFC). Das persistierende alveoläre Ödem ist ein typisches Merkmal des 
ARDS und kann teilweise auf eine gestörte Na+ und Flüssigkeitsreabsorption zurückgeführt 
werden, was mit einem schlechteren Outcome assoziiert ist. Daher sind die Auswirkungen von 
Hyperkapnie auf die alveolarepitheliale ENaC-Funktion und die Identifikation der Signalwege, die 
durch eine Herunterregulierung von ENaC die Ödem-Clearance bei hyperkapnischen Patienten mit 
ARDS beeinträchtigen können, von hoher klinischer Relevanz. 
Die vorliegende Arbeit beschreibt die molekularen Mechanismen, durch die Hyperkapnie die 
Expression von ENaC auf der Zelloberfläche in Alveolarepithelzellen (AECs) reduziert und somit 
den ENaC-getriebenen transepithelialen Na+-Transport beeinträchtigt. Wir beschreiben, dass eine 
akute Hyperkapnie, unabhängig vom pH-Wert (pCO2 ~ 120 mmHg, pH 7,4 für 30 min), zur 
Polyubiquitinierung des β-ENaC und anschließender Endozytose des α/β-ENaC-Komplexes von 
der Zelloberfläche von primären Ratten-ATII- und menschlichen A549 Alveolarepithelzellen 
führte, wie durch Zelloberflächen-Biotinylierung und Fluoreszenzmikroskopie bestimmt wurde. 
Im Gegensatz dazu veränderte Hyperkapnie weder die mRNA noch die intrazellulären 
Konzentrationen von ENaC-Proteinen, was darauf hindeutet, dass akut erhöhte CO2-Werte eher 
der zellulären Lokalisation des Kanals als dessen Transkription oder Abbau beeinflussen. Des 
Weiteren zeigten unsere Daten, dass Hyperkapnie durch Verringerung der ENaC-
Zelloberflächenexpression sowohl den gesamten (Isc) als auch den amilorid-sensitiven (Iamil-sens) 
Na+-Strom in humanen H441 Atemwegsepithelzellen reduziert. Ferner führte Hyperkapnie zu einer 
Polyubiquitinierung des β-ENaC und der Endozytose des α/β-ENaC-Komplexes, welches durch 
eine genetische Ablation der E3-Ubiquitin-Ligase, Nedd4-2, gehemmt werden konnte. Co-
Immunpräzipitationsstudien bestätigten die direkte Interaktion von Nedd4-2 mit der β-Untereinheit 
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von ENaC. Vordergründig war, dass die CO2-induzierte β-ENaC-Ubiquitinierung und die 
Endozytose des α/β-ENaC von der Zelloberfläche stark von der extrazellulären Signal-regulierten 
Kinase (ERK)1/2, welche β-ENaC direkt am T615 phosphoryliert, abhängig waren. Im Einklang 
mit diesen Erkenntnissen, normalisierte die Transfektion von A549-Zellen mit einer β-ENaC-
Mutante, mit fehlendem T615, die Zelloberflächendichte von α/β-ENaC bei hyperkapnischer 
Exposition. Die Aktivierung von ERK1/2 führte zu einer nachfolgenden Aktivierung der AMP-
aktivierten Proteinkinase (AMPK) und c-Jun-N-terminalen Kinase (JNK)1/2, die wiederum 
Nedd4-2 am T899 phosphorylierte. Der Ersatz des T899 durch ein Alanin (T899A), das die JNK-
vermittelte Phosphorylierung von Nedd4-2 verhinderte, inhibierte signifikant die 
Polyubiquitinierung von β-ENaC und erhöhte die Zelloberflächenexpression des α/β-ENaC-
Komplexes bei der CO2-Behandlung. Die pharmakologische Hemmung von JNK führte ebenso zur 
ENaC-Stabilisierung auf der Zelloberfläche nach Hyperkapnie. Zusätzlich verhinderte die 
chemische Inhibierung oder die genetische Ablation von AMPK die, durch Hyperkapnie 
induzierte, β-ENaC-Polyubiquitinierung und Internalisierung des α/β-ENaC-Komplexes. Eine 
vergleichbare Reduktion der ENaC-Endozytose nach Behandlung mit Hyperkapnie wurde 
beobachtet, wenn eine Upstream-gelegene Kinase von AMPK, die Ca2+/Calmodulin-abhängige 
Proteinkinase-β (CaMKK-β), inhibiert wurde. Dies bestätigt, dass die Aktivierung von AMPK 
benötigt wurde, um ENaC während einer akuten Hyperkapnie herunterzuregulieren. Folglich 
beschreiben wir ein neuartiges CO2-induziertes Signalmuster in Alveolarepithelzellen, das durch 
Aktivierung der ERK/AM/JNK-Achse die Expression und Funktion von ENaC auf der 
Zelloberfläche beeinflusst, indem es die Ubiquitinierung von β-ENaC fördert und die 
anschließende Internalisierung des Kanals vorantreibt. Diese Signalkaskade kann den alveolären 
Flüssigkeitshaushalt weiter beeinträchtigen und somit zu schlechteren Outcomes bei Patienten mit 
ARDS führen und einen potenziell adressierbaren Signalweg darstellen, der zur Entdeckung neuer 
Therapien gegen Alveolarödem bei Patienten mit hyperkapnischem respiratorischem Versagen 
führen könnte. 
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Abbreviations 
A  Alanine  
A549  Human adenocarcinoma alveolar epithelial cell  
A6  Xenopus laevis kidney cell 
AEC Alveolar epithelial cell 
AECC American-European consensus conference 
AFC Alveolar fluid clearance  
ALF Alveolar lining fluid 
ALI  Acute lung injury  
ALTA Albuterol to Treat Acute Lung Injury 
AMP  Adenosine monophosphate  
AMPK  AMP-activated protein kinase 
AQP5 Aquaporin 5 
AP-2 Adaptor protein 2 
ARDS  Acute respiratory distress syndrome  
ATI  Alveolar epithelial type I cell  
ATII  Alveolar epithelial type II cell 
BSA  Bovine serum albumin  
C2 Calcium binding domain of Nedd4-2 
Ca2+  Calcium ion 
Calu-3 Human airway epithelial cell line 
CAP Channel activating protease 
CaMKK-β  Ca2+/calmodulin-dependent kinase kinase β 
cAMP Cyclic adenosine monophosphate 
cDNA  Complementary deoxyribonucleic acid 
CF  Cystic fibrosis 
CFTR  Cystic fibrosis transmembrane conductance regulator 
CHO  Chinese hamster ovary cell 
CNG Cyclic nucleotide gated channel 
CO2  Carbon dioxide  
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Co-IP Co-immunoprecipitation 
COOH  C-terminus of protein with free carboxyl group  
COPD  Chronic obstructive pulmonary disease  
Ctrl  Control  
DAPI 4',6-diamidino-2-phenylindole 
Deg  Degenerin 
DMEM  Dulbecco's modified Eagle's medium  
DMSO  Dimethyl sulfoxide  
DNA  Deoxyribonucleic acid  
DTT  Dithiothreitol  
DUB Deubiquitinating enzyme 
E1   Ubiquitin-activating enzyme  
E2  Ubiquitin-conjugating enzyme  
E3  Ubiquitin ligase  
E. coli Escherichia coli 
EGF Epithermal growth factor 
ENaC  Epithelial sodium channel  
ER  Endoplasmic reticulum  
ERK  Extracellular signal-regulated kinase  
FBS  Fetal bovine serum  
FiO2   Fraction of inspired oxygen  
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GFP  Green fluorescence protein  
GILZ1 Glucocorticoid-induced leucine zipper protein-1 
h Hour 
H441 Human airway epithelial cell 
HA  Hemagglutinin  
HECT  Homologous to the E6-AP carboxyl terminus  
HRP  Horseradish peroxidase  
HSC  Highly selective channel 
Iamil-sens  Amiloride-sensitive current 
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ICU  Intensive care unit 
IgG  Immunoglobulin G  
IL Interleukin 
Isc  Short-circuit current 
ITS Insulin-transferrin sodium selenite 
JNK  c-Jun N-terminal kinase 
kb  Kilo base 
KGF Keratinocyte growth factor 
KCa Calcium-activated potassium channel 
Kv Voltage-gated potassium channel 
LB  Luria-Bertani  
LPS  Lipopolysaccharide 
M1, M2 Transmembrane domains of ENaC  
MAPK Mitogen-activated protein kinase 
MARCKS Myristoylated alanine-rich C-kinase substrate 
mCT1 Murine collecting duct epithelial cells 
MSC Mesenchymal stem (stromal) cells 
MDCK Madin-Darby canine kidney 
mmHg  Millimeters of mercury  
mRNA  Messenger RNA  
n Number of independent experiments 
NCBI  National Center for Biotechnology Information 
Nedd4-2  Neural precursor cell expressed developmentally down-regulated protein 4-2 
NH2  N- terminus of the protein with free amine group 
Na,K-ATPase  Sodium-potassium adenosine triphosphatase 
NO Nitric oxide 
ns Not significant 
NSC Non-selective channel 
PaO2  Arterial partial pressure of oxygen  
PBS  Phosphate-buffered saline  
PCR  Polymerase chain reaction  
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PEEP  Positive end-expiratory pressure  
pHe  Extracellular pH  
pHi  Intracellular pH 
PHA Pseudohypoaldosteronism 
PIP2 Phosphatidylinositol biphosphate 
PKA Protein kinase A 
PKC Protein kinase C  
Po  Open probability 
PM Plasma membrane 
PY PPPXY, P-proline, X-any amino acid and Y-tyrosine  
RNA  Ribonucleic acid  
ROS  Reactive oxygen species  
RPMI 1640  Roswell Park Memorial Institute 1640 medium 
rpm  Rounds per minute 
rtPCR  Reverse transcription polymerase chain reaction  
SCNN1 Sodium channel non-neuronal 1 
SDS-PAGE  Sodium dodecyl sulfate-polyacrylamide gel electrophoresis  
SEM  Standard error of mean 
SGK1 Serum- and glucocorticoid- induced protein kinase-1  
siRNA Small interfering RNA 
SOC Medium salt-optimized with carbon (glucose)-medium 
T Threonine 
TEER  Transepithelial electrical resistance  
TGF-β Transforming growth factor-β  
TIP Lectin-like domain of TNF-α 
TNF  Tumor necrosis factor  
TfR Transferrin receptor 
T-TBS  Tween 20-tris-buffer saline  
Ub Ubiquitin 
UCH-L3 Ubiquitin carboxyl-terminal hydrolase isozyme L3 
V5  Epitope tag derived from paramyxovirus of simian virus 5 
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VILI  Ventilator-induced lung injury 
Vt  Tidal volume 
WNK1 With no lysine 2 
WW Tryptophan rich domain of Nedd4-2 
WT  Wild-type  
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1. Introduction  
1.1 Overview of acute respiratory distress syndrome (ARDS) 
Acute respiratory distress syndrome (ARDS) remains one of the most common clinical problems 
encountered in intensive care units (ICU). The syndrome has a high incidence, in the United States 
approximately 200,000 patients present annually with a lethal outcome in up to 40% of these 
patients (Rubenfeld and Herridge 2007). Globally, 5.5 millions of patients per year need an ICU 
admission and mechanical ventilation (Adhikari et al. 2010). ARDS is a life-threatening condition 
that is associated with formation of pulmonary edema that disturbs gas exchange leading to 
hypoxemia and impaired carbon dioxide elimination (Matthay and Zemans 2011). Based on the 
current definition of ARDS, the so called Berlin Definition from 2012, the syndrome is 
characterized by acute onset of bilateral airspace infiltrates with arterial hypoxemia without left 
arterial hypertension and can be classified as mild, moderate or severe depending on the extent of 
hypoxemia (Ranieri et al. 2012). This new definition of ARDS improved and simplified the 
previous one proposed in 1994 at an American-European consensus conference on ARDS (AECC) 
(Bernard et al. 1994). The severity of ARDS is classified by the ratio of arterial partial pressure of 
oxygen (PaO2) to the fraction of inspired oxygen (FiO2). Patients with PaO2/FiO2 of 300, 200 or ≤ 
100 mmHg suffer from mild moderate or severe ARDS, respectively, whereas per definition 
patients with ARDS require mechanical ventilation with a positive end-expiratory pressure (PEEP) 
of 5 cm H2O or higher (Ranieri et al. 2012). 
There are numerous clinical conditions that may lead to ARDS, some of which directly affect the 
lung, such as viral or bacterial pneumonia, aspiration of gastric contents, pulmonary contusions or 
near-drowning, whereas other noxae are primarily extra-pulmonary including non-pulmonary 
sepsis, pancreatitis, severe poly-trauma or drug overdose (Ware and Matthay 2001; Ranieri et al. 
2012). During ARDS the injured lungs undergo pathogenic changes in three major phases: 
exudative, proliferative and fibrotic. The destruction of vascular endothelium, epithelium, 
recruitment and accumulation of neutrophils, macrophages and blood cells in the alveolar 
compartment together with the presence of alveolar edema are key features of the exudative phase 
of ARDS. The proliferative stage of ARDS is characterized by pneumocyte hyperplasia and 
myofibroblast proliferation, whereas collagen deposition and fibroproliferation are hallmarks of 
the fibrotic phase (Bachofen and Weibel 1982; Meyrick 1986). The injuries of the lung endothelial 
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and epithelial barriers caused predominantly by neutrophil- and platelet-dependent damage are 
detected in ARDS patients however, an endothelial injury per se is not sufficient to cause ARDS. 
Early studies in sheep clearly demonstrated that alveolar fluid clearance (AFC) remained normal 
in the presence of lung vascular permeability enhancement as long as the alveolar epithelial barrier 
was intact. In contrast, when live bacteria impaired the integrity of the epithelium, AFC markedly 
decreased (Wiener-Kronish et al. 1991). This study established that persistence of excess fluid in 
the alveolar space occurs only when endothelial injuries are accompanied by an impairment of 
epithelial barrier function. These data are in line with the notion that lung biopsies from patients 
with ARDS show diffuse alveolar epithelial and endothelial damage (Bachofen and Weibel 1977).  
The mechanisms of epithelial and endothelial damage during ARDS are complex and dependent 
on the cause of ARDS. Several studies suggested that active neutrophils by secreting toxic 
mediators such as proteases or reactive oxygen species (ROS) may cause disruption of cell 
junctions and death of alveolar epithelial and endothelial cells leading to accumulation of protein-
rich alveolar edema (Herold et al. 2013). Integrity of the alveolar-capillary barrier function is 
crucial to prevent alveolar flooding but also to actively remove excess alveolar liquid thus allowing 
optimal gas exchange. In contrast, impairment of epithelial barrier integrity leads to formation and 
persistence of alveolar edema, which are the hallmarks of ARDS (Bachofen and Weibel 1977).  
Currently, there is a lack of effective pharmacological therapies for patients with ARDS. While 
various agents showed promise in preclinical trials, unfortunately so far these have not translated 
into therapeutic modalities in the clinical setting. For example, inhaled synthetic surfactant, 
antibodies against bacterial endotoxins or corticosteroids have been tested in clinical trials but none 
of them were effective (Raghavendran et al. 2008; Raghavendran et al. 2011). Moreover, the use 
of  nitric oxide (NO), a potent pulmonary vasodilator improved oxygenation but did not improve 
outcomes (Taylor et al. 2004). Also, stimulation of β2-adrenergic receptors increases vectorial 
sodium transport and improves edema clearance in various animal models and alveolar epithelial 
cells (Sznajder 2001; Mutlu et al. 2004). However, the use of β2-agonist in the treatment of ARDS 
was not beneficial in the recent “Albuterol to Treat Acute Lung Injury (ALTA)” study in which no 
difference in the primary outcome of ventilator-free days between the placebo and albuterol groups 
was evident (Matthay et al. 2011). Similarly, promising findings in a human lung injury model 
were the basis for clinical trials applying keratinocyte growth factor (KGF) for the treatment of 
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ARDS. KGF has been presented as a modulator of several mechanisms potentially important for 
alveolar epithelial repair however, the results of a most recent clinical trials showed no 
improvement in outcomes of patients with ARDS (Shyamsundar et al. 2014; McAuley et al. 2017). 
An attractive therapeutic option for ARDS is cell-based therapy with bone marrow–derived 
mesenchymal stem (stromal) cells (MSCs). Based on various preclinical studies the beneficial 
effects of MSCs are mediated by paracrine secretion of anti-inflammatory cytokines, keratinocyte 
growth factor, angiopoietin-1and anti-microbial peptides that decrease inflammation and promote 
repair of the injured alveolar epithelium. Interestingly, treatment with human MSCs re-establishes 
alveolar fluid clearance in endotoxin-induced acute lung injury in ex vivo perfused human lungs 
partly by restoring amiloride-dependent sodium transport, suggesting that MSC-derived factors 
may have beneficial effects on apical sodium absorption mediated by ENaC (Matthay 2015). 
Because of the promising preclinical data in studies performed in mice, studies in large animal 
models of ARDS and ex vivo perfused human lungs, some clinical trials are now on-going. 
Currently, mechanical ventilation, fluid management and prone positioning are the supportive 
therapeutic possibilities used for reestablishing oxygenation in patients with ARDS (Wiedemann 
et al. 2006; Johnson and Matthay 2010; Guérin et al. 2013). Importantly, mechanical ventilation 
per se is harmful for lungs even if low tidal volumes (Vt) are used, a condition that is termed 
ventilator-induced lung injury (VILI) (Biehl et al. 2013). It has been reported that PEEP may be 
beneficial due to prevention of alveolar collapse in mechanically-ventilated patients with ARDS 
(Briel et al. 2010; Chikhani et al. 2016). PEEP improves arterial oxygenation but also leads to the 
impairment of oxygen delivery to tissues that may explain the ambiguous effects of various PEEP 
levels on survival. Another ventilator setting that clearly affects outcome is the Vt. Until the late 
1990s a high Vt of 10 to 12 ml/kg ideal body weight was widely used. However, it became 
increasingly evident that while initially improving oxygenation such large tidal volumes caused 
lung inflammation and disruption of the alveolar-capillary barrier, ultimately hypoxemia and 
further deterioration of patients with ARDS (Cheng et al. 2005). A landmark study of the ARDS 
Network in 2000 showed that ventilation with lower tidal volumes (~6 ml/kg) decreases harmful 
stretch of the lung, release of inflammatory mediators and markedly reduces mortality. This 
ventilation strategy is clearly beneficial for patients with ARDS (when compared to ventilation 
with high Vt) however, it may lead to retention of carbon dioxide and thus respiratory acidosis 
(ARDSNetwork 2000).  
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1.2 Hypercapnia 
Carbon dioxide is generated as a waste product during cellular respiration and its removal from the 
blood occurs during ventilation. Normal partial pressure of arterial blood CO2 (PaCO2) is 35-45 
mmHg in healthy individuals but patients with lung diseases such as chronic obstructive lung 
disease (COPD), cystic fibrosis (CF) and ARDS develop aberrations in gas exchange that lead to 
the accumulation of CO2 in the blood and tissue, a condition termed hypercapnia (Laffey and 
Kavanagh 1999; Mutlu et al. 2002; Belkin et al. 2006). Moreover, patients who are mechanically 
ventilated with low tidal volumes may have a further CO2 retention due to alveolar hypoventilation 
(Vadász et al. 2012; Bellani et al. 2016).  
Increased concentrations of carbon dioxide decrease pH levels in the blood, leading to respiratory 
acidosis that may have anti-inflammatory effects (Curley et al. 2010). Since excessive 
inflammation is a hallmark of ARDS, it has been proposed that hypercapnia may improve outcomes 
in patients with ARDS (Ryu et al. 2012). In this regard, some investigators suggested that 
hypercapnia may be tolerated (the concept of “permissive” hypercapnia) or even induced 
(“therapeutic” hypercapnia) to limit inflammation. Although elevated CO2 levels have been shown 
to impair neutrophils function, reduce pro-inflammatory cytokines and inhibit ROS production, 
these effects are most likely due to the hypercapnia-associated acidosis rather than hypercapnia 
itself (Curley et al. 20010). Furthermore, it has been reported that buffering hypercapnic acidosis 
fails to improve ALI secondary to infections (Higgins et al. 2009; Nichol et al. 2009). Indeed, most 
recent clinical trials suggest that an elevated CO2 level is an independent risk factor and is 
associated with worse outcomes in critically ill patients,  particularly in patients with ARDS (Nin 
et al. 2017; Tiruvoipati et al. 2017).  
There are several factors that may contribute to the decreased survival of hypercapnic patients with 
ARDS. For instant, hypercapnia independently of changes in pH impairs innate immunity and lung 
host defense, leading to a decreased resistance of patients to bacterial infections (Helenius et al. 
2009; Wang et al. 2010). In lipopolysaccharide-stimulated human and mouse macrophages 
exposed to elevated CO2 concentrations, expression levels of cytokines directly implicated in 
antimicrobial host defense such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were 
significantly reduced (Wang et al. 2010). Moreover, an immunosuppressive effect of hypercapnia 
has been reported in a study that investigated  Pseudomonas aeruginosa-infected mice (Gates et 
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al. 2013). In these experiments, elevated CO2 levels reduced bacterial clearance from the lungs and 
allowed dissemination of Pseudomonas aeruginosa to other organs leading to increased mortality. 
Additionally, several reports showed that hypercapnia independently of changes in pH, ROS or 
carbonic anhydrases alters reabsorption of alveolar fluid by a mechanism that leads to Na,K-
ATPase downregulation (Briva et al. 2007; Chen et al. 2008; Vadász et al. 2008). Interestingly, 
hypercapnia induces phosphorylation of the cellular energy sensor AMP-activated protein kinase 
(AMPK). Activated AMPK drives protein kinase C (PKC)-ζ translocation to the cellular surface, 
where PKC-ζ phosphorylates the α-subunit of the Na,K-ATPase leading to its internalization and 
thus inhibition of lung fluid clearance (Vadász et al. 2008). Moreover, a member of the mitogen-
activated protein kinases (MAPK) family, c-Jun N-terminal kinase (JNK)1/2 is also involved in 
the hypercapnia-induced endocytosis of Na,K-ATPase in humans, mice, rats and in Drosophila 
melanogaster (Vadász et al. 2012). It has been described that hypercapnia-induced activation of 
JNK promotes internalization of Na,K-ATPase via phosphorylation of LMO7b (a scaffolding 
protein) at the Ser1295 residue (Dada et al. 2015). Moreover, long-term hypercapnia induces the 
activation of miR183 that downregulates isocitrate dehydrogenese 2 leading to mitochondrial 
dysfunction and inhibited proliferation of AEC (Vohwinkel et al. 2011).  
Notably, CO2 has been presented as a signaling molecule that impacts the level of important cellular 
second messengers such as intracellular calcium [Ca2+]i or cyclic adenosine monophosphate 
(cAMP). For example, increased [Ca2+]i levels were demonstrated in alveolar epithelial type II cells 
exposed to hypercapnia (Vadász et al. 2008). It has been shown that the elevated [Ca2+]i levels 
secondary to hypercapnia and independently of pH led to rapid CaMKK-β-dependent activation of 
AMPK and subsequent inhibition of Na,K-ATPase thus impairing alveolar epithelial function. In 
contrast, human endothelial cells treated with hypercapnia present only a minor increase in [Ca2+]i, 
suggesting that epithelial cells probably exhibit different CO2 sensing mechanisms compared to 
endothelial cells (Nishio et al. 2001). Moreover, hypercapnia has been shown to inhibit the cAMP-
dependent cystic fibrosis transmembrane conductance regulator (CFTR) in primary human airway 
epithelia (Calu-3) (Turner 2014).  
Although the CO2 sensor remains unidentified, recent scientific reports suggest that the level of 
CO2 is sensed in lung cells. It has been well characterized that hypercapnia is sensed by excitable 
cells such as the glomus cells of the carotid body (Putnam et al. 2004). In these cells, elevated CO2 
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levels lead to depolarization causing an increase in alveolar ventilation in order to maintain regular 
CO2 levels in the body. In contrast to neuronal cells, the impact of elevated CO2 levels on non-
excitable mammalian cells has been less investigated however, recent studies suggest that 
hypercapnia initiates specific signaling patterns in the alveolar epithelium leading to 
downregulation of ion transport proteins and thus has potential deleterious effects on lung function 
(Briva et al. 2007; Chen et al. 2008; Vadász et al. 2008).  
1.3 Alveolar epithelial Na+ and fluid transport 
The surface of the lung is formed by numerous epithelial cells that provide a continuous layer and 
represent a physical barrier against environment insults (Jeffery and Reid 1975; Denker and Nigam 
1998). The structural integrity of pulmonary epithelial cells that are sealed together via tight 
junctions allows ions transport and gas exchange. The human lungs have a  total surface area of 
approximately 130 m2 and a major part of this area is represented by the alveolar region, which 
shows an asymmetric distribution of apically- and basolaterally-located ion transporters 
(Hollenhorst et al. 2011) (Figure 1.1). 
Figure 1.1 Scheme of ion transport proteins expressed in alveolar epithelial type I and type 
II cells. Epithelial sodium channel (ENaC), cyclic nucleotide-gated channel (CNG), sodium, 
potassium adenosine triphosphatase (Na,K-ATPase), voltage gated potassium channel (Kv), 
inward rectifying potassium channel (Kir), calcium-activated potassium channel (KCa), potassium 
channel with unknown molecular identity (?), cystic fibrosis transmembrane conductance regulator 
(CFTR), aquaporin 5 (AQP5). Figure was modified from Hollenhorst et al. 2011. 
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In mammalian lungs, alveolar type I (ATI) and type II (ATII) cells form the epithelial surface of 
the alveoli (Stone et al. 1992). Type II cells are cuboidal in shape and are characterized by the 
ability to produce and secrete surfactant. The majority of the alveolar region (95%) is covered by 
ATI cells which are larger and very thin therefore, reducing diffusion distance between the alveolar 
airspace and capillary blood. The main function of the alveoli is gas exchange during which oxygen 
from the airspace is transported into the blood and carbon dioxide out of the blood. However, 
efficient gas exchange requires precise regulation of the alveolar lining fluid (ALF) that covers the 
luminal surface of the alveolar epithelium (Scarpelli 2003). 
The volume of the ALF depends on the equilibrium between passive fluid secretion from the 
vascular space and active fluid reabsorption from the alveoli (Matthay et al. 2002; Fronius et al. 
2012). Accumulation of excess fluid in the alveolar space can be a consequence of impaired 
alveolar fluid clearance (AFC) and/or epithelial hyperpermeability initiated by a disruption of the 
epithelial barrier. The failure of the lungs to remove edema fluid (complication hallmark of ARDS) 
correlates with higher mortality (Ware and Matthay 2001). Resolution of the alveolar edema 
depends on the active transport of salt and water across the distal lung epithelium (Matthay and 
Zemans 2011).  
There are numerous studies showing that fluid reabsorption in the lungs is a direct consequence of 
a two-step process of transepithelial Na+ transport across the alveolar epithelium (Berthiaume et 
al. 1987; Jain et al. 1999; Matalon and Brodovich 1991). Na+ ions enter the cells via amiloride-
senstive, epithelial sodium channel (ENaC) expressed in the apical membrane of epithelial cells, 
next Na+ is actively transported into the lung interstitium by the basolaterally located Na,K-
ATPase. The process of Na+ reabsorption produces a transepithelial osmotic gradient that drives 
passive movement of water to the interstitium. The removal of water takes place primarily 
paracellularly (Figure 1.2). Originally, it has been hypothesized that only ATII cells participate in 
active Na+ transport across the alveolar epithelium. Recent studies using isolated ATI cells show 
that type I pneumocytes also express ion transporters including ENaC and Na,K-ATPase and are 
capable of active Na+ transport (Flodby et al. 2016).  
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Figure 1.2 Scheme of vectorial Na+ transport mediated by ENaC and Na,K-ATPase across 
alveolar epithelial cells. Na+ enters alveolar epithelial cells through apically located and sodium 
permeable epithelial sodium channels, ENaCs and it is transported across the basolateral side of 
membrane via Na,K-ATPases. The active transport of Na+ generates a transepithelial osmotic 
gradient and drives the movement of water out of the alveolar airspace.  
1.4 Structural characteristics of ENaC  
The epithelial sodium channel (ENaC) is also known as sodium channel non-neuronal 1 (SCNN1) 
and belongs to the ENaC/degenerin superfamily (Rossier et al. 2002). The highly selective ENaCs 
are composed of three non-identical (approximately 30% of sequence identity), but structurally 
related subunits named α, β, and γ that are most probably arranged in a heterotrimeric structure to 
form a fully functional protein (Bhalla and Hallows 2008). Studies in Xenopus oocytes showed that 
expression of all three ENaC subunits is necessary to mimic the channel features similar to those 
observed in native tissue, whereas co-expressing of either α-ENaC alone or combination of α/β-or 
α/γ-ENaC in oocytes produced smaller amiloride-sensitive current (Canessa et al. 1994; 
McNicholas and Canessa 1997; Bonny et al. 1999). These results clearly demonstrated that α-ENaC 
is the pore-forming subunit necessary for transepithelial Na+ transport, while the β- and γ-subunits 
play a regulatory role in channel function, probably by controlling trafficking of the ENaC complex 
to the apical surface of the cells. 
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Additionally, two other ENaC subunits termed δ and ε have been described recently (Babini et al. 
2003; Schwagerus et al. 2015). The latter one has been found in Xenopus renal cells (Babini et al. 
2003) in contrary, the δ-subunit has been detected in respiratory epithelial cells of various species 
including human primary alveolar type II cells however, δ-ENaC is absent in rats and mice 
(Schwagerus et al. 2015). Some studies suggest that the δ-subunit, which is rather similar to α-
ENaC can form a functional channel together with the β- and γ-subunits (Waldmann et al. 1995). 
Interestingly, δβγ-ENaC presents different sensitivity to amiloride than the αβγ-complex and has a 
higher single-channel Na+ conductance (∼12 pS) (Haerteis et al. 2009). Of note, Ly and coworkers 
have shown that the amiloride-sensitive current generated by δβγ-ENaC is reduced by Nedd4-2 
however, the inhibition is probably mediated by the β- or γ-subunits ubiquitination due to the lack 
of a Nedd4-2 binding site in δ-ENaC (Ly et al. 2013).  
Each ENaC subunit has a strictly defined topology, including two transmembrane segments (M1 
and M2), a large extracellular loop, as well as a short NH2- and COOH-terminal tail located 
intracellularly (Canessa et al. 1994) (Figure 1.3).  
Figure 1.3 Scheme of ENaC topology. α-, β- and γ-subunit of ENaC are assembled into a 
heterotrimeric complex to create Na+ selective channels expressed at the apical side of the cellular 
membrane. Each subunit contains two membrane spanning domains (M1, M2), an extracellular 
loop and cytoplasmic NH2- and COOH-termini.  
The membrane spanning domains of ENaC are important for regulation of channel conductance 
and cation selectivity (Ji et al. 2001). Prior to insertion into the cell surface (functional channel 
expression), ENaC undergoes maturation processes that are associated with N-linked glycosylation 
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and proteolytic cleavage of the α- and γ-subunits by intracellular proteases (Bhalla and Hallows 
2008). Interestingly, a point mutation of cysteines that are localized in the extracellular loop of the 
channel prevented glycosylation and decreased channel delivery to the cell surface without 
effecting ENaC degradation, suggesting a role for the extracellular loop in channel trafficking 
(Green and Wanamaker 1997). Moreover, ENaC is inhibited by potassium-sparing diuretic 
amiloride (Renard et al. 1994) that is commonly used to estimate the contribution of the channel to 
transepithelial Na+ transport. Several studies have addressed the question concerning the 
mechanism by which amiloride binds and inhibits ENaC and revealed that the M2 domain as well 
as the extracellular loop of α-ENaC are important for amiloride binding (Schild et al. 1997; Ji et al. 
2001).  
Notably, the intracellular tails of ENaC play a central role in the regulation of ENaC endocytosis 
and thus channel function. The cytoplasmic COOH-terminus contains a unique proline-rich domain 
(PY or PPxY motif) that is critically important for protein-protein interactions including the 
interaction with neural precursor cell expressed developmentally down-regulated protein (Nedd4-
2) that mediates ubiquitin-dependent ENaC endocytosis (Abriel et al. 1999; Rotin and Staub 2011) 
and extracellular signal–regulated kinases (ERK)1/2 which directly phosphorylate β- and γ-ENaC 
(Shi et al. 2002). The intracellular N-terminus of ENaC participates in channel subunit assembly 
and gating (Adams et al. 1997; Prince and Welsh 1998). Interestingly, lysine residues located at 
this part of ENaC play an important role in endocytic retrieval of ENaC driven by Nedd4-2 
mediated ubiquitination (Rotin and Staub 2012).  
1.5 Tissue distribution and physiological roles of ENaC 
ENaC is localized at the apical membrane of several epithelial tissues including lung, kidney, 
gastrointestinal tract, sweat glands and it is the rate-limiting step of Na+ absorption. The proper 
function of ENaC is crucial for regulating total body salt and water homeostasis and normal blood 
pressure (Stockand et al. 2008; Butterworth 2010). In addition, ENaC is found in taste cells of the 
tongue, where most likely is a receptor for salt taste (Boughter et al. 1999) and in non-epithelial 
cells such as in specialized cutaneous sensory neurons where it plays a role in mechanosensation 
(Drummond et al. 2000).  
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In the lungs, ENaC is expressed in airway epithelial cells including Clara cells located in the distal 
airways and in both types of alveolar epithelial cells, in which it is responsible for maintaining 
alveolar fluid balance and consequently for optimal gas exchange (Matalon et al. 2002; Matalon et 
al. 2015). In this regards, abnormalities in ENaC function are associated with several diseases such 
as an inherited, autosomal-dominant salt-sensitive form of hypertension (Liddle’s syndrome), a 
disorder that is directly linked to changes in ENaC cell surface expression due to the presence of 
characteristic mutations within the PY motif of the β- and γ-subunits that affect channel endocytosis 
(Abriel et al. 1999). Interestingly, a commonly used mouse model to study CF is characterized by 
β-ENaC overexpression. Mall and colleagues presented that overexpression of β-ENaC in mice 
leads to hyperabsorption of Na+ and lung dehydration most probably due to abnormally high ENaC 
trafficking to the cellular surface (Mall et al. 2004). In contrary, reduction in ENaC function leads 
to an excess of lung fluid resulting from impaired Na+ and water reabsorption. This type of ENaC 
dysfunction is observed in patients with type I pseudohypoaldosteronism (PHA1) (Kerem and 
Bistritzer 1999) and pulmonary edema (Matalon et al. 2002; Matalon et al. 2015).  
1.5.1 Role of ENaC in lung fluid homeostasis 
Fluid reabsorption across the distal lung epithelium is primarily driven by vectorial Na+ transport 
that allows water clearance. This process is crucial for maintaining the alveolar space “dry” in order 
to allow normal oxygen and carbon dioxide exchange (Canessa et al. 1994; Matthay et al. 2002; 
Matalon et al. 2015). Up to date, several Na+ channels have been found in alveolar epithelial cells, 
including the ones that are sensitive and those that are insensitive to amiloride. Two types of 
amiloride-sensitive channels are expressed in the alveolar epithelium, the highly selective Na+ 
channels (HSC) such as ENaC and the non-selective cation channels (NSC) (Matthay et al. 2002; 
Althaus et al. 2011). 
Since it has been demonstrated in studies in isolated lung models and in vivo using animals that 
addition of amiloride inhibits transepithelial Na+ transport and AFC, it is believed that amiloride-
sensitive sodium channels (ENaC-like channels) represent a key element of Na+ uptake in alveolar 
epithelial cells and that they have a major contribution to alveolar fluid reabsorption (Basset et al. 
1987; Matalon et al. 2002; Eaton et al. 2004).  
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The significance of ENaC in alveolar fluid balance has been shown in the studies described by 
Hummler et al., in which α-ENaC knock-out mice died early after birth (within 40 h) due to 
defective lung fluid clearance (Hummler et al. 1996).  
An additional example underlining the role of ENaC in alveolar fluid clearance was demonstrated 
by lung-specific α-ENaC knock-down studies in rats in vivo, in which silencing of α-ENaC 
decreased AFC after β-adrenoceptor stimulation, whereas application of amiloride did not cause 
further AFC inhibition. These findings also suggested that β-adrenoceptor stimulation of AFC is 
dependent on ENaC expression (Li and Folkesson 2006). 
These studies established amiloride-sensitive channels as crucial regulators of AFC. However, it is 
still not fully understood how Na+ transporters are regulated during pathological conditions such 
as acute lung injury. Recent studies have shown that lung infections induce inflammatory cytokines 
and chemokines such as TNF-α, transforming growth factor beta 1 (TGF-β1) or interleukin 1 beta 
(IL-1β) that alter ENaC-mediated Na+ transport (Wynne et al. 2017). Given the importance of 
ENaC in lung fluid balance, upregulation of these inflammatory cytokines and chemokines may 
significantly contribute to the persistence of pulmonary edema in patients with ARDS secondary 
to pneumonia (Figure 1.4). Since ENaC activity controls lung fluid homeostasis, one of the 
potential mechanisms to increase AFC under pathological conditions is to enhance  the abundance 
of the channel at the apical surface of alveolar epithelial cells, which may lead to the improvement 
of patient outcomes (Ware and Matthay 2001; Geiser 2003; Bhattacharya and Matthay 2013).  
Figure 1.4 The role of cytokines in mediating ARDS. During lung infections, inflammatory 
cytokines are produced and lead to ENaC downregulation. The reduction in ENaC activity inhibits 
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reabsorption of excess alveolar fluid, thus impairing gas exchange. The figure was modified from 
Wynne et al. 2017. 
1.6 Aspects of ENaC regulation  
Because decreased ENaC function impairs resolution of pulmonary edema, studying the exact 
molecular mechanisms of ENaC regulation is important for understanding lung fluid homeostasis. 
ENaC function can be modified by a variety of extra- and intracellular factors. The NH2- and 
COOH- termini of ENaC provide sites of protein binding and chemical modification in response 
to cellular signals that regulate channel activity by either modifying the open probability (Po) or by 
varying the number of the channels located at the apical membrane of cells (Anantharam et al. 
2006; Kashlan and Kleyman 2012).  
1.6.1 Regulation of ENaC via open probability (Po) 
Our knowledge is limited regarding the factors that alter open probability of ENaC. However, 
mutations of specific residues within the intracellular N-terminal tail of α-ENaC result in low Po, 
suggesting that this segment of the channel structure is important for gating control (Grunder et al. 
1999). For example, regulation of ENaC activity by phosphatidylinositol 4,5-bisphosphate (PIP2) 
has been shown in studies in renal A6 collecting duct cells in which PIP2 binding to the N-terminal 
domain of β and γ-ENaC increased single channel open probability  (Yue et al. 2002). Furthermore, 
an increase in extracellular Na+ concentration decreases ENaC activity by altering channel gating. 
This process is called Na+ self-inhibition, occurs over seconds and can be blunted by treatment 
with external trypsin (Chraïbi and Horisberger 2002). In contrast, an increase in intracellular Na+ 
levels (feedback inhibition) results in slower changes in ENaC activity. Interestingly, Kellenberger 
et al. demonstrated that channels with Liddle's syndrome mutation expressed in oocytes did not 
respond to Na+-dependent inhibition, suggesting that the enhancement of ENaC activity in patients 
with Liddle's syndrome may be driven by a mechanism that decreases feedback inhibition 
(Kellenberger et al. 1998).  
Regulation of channel open probability may also occur as a result of proteolytic cleavage of ENaC 
subunits (Eaton et al. 2010). It is well known fact that the α- and γ-subunits of ENaC contain a 
furin cleavage site. Furin is a serine protease that is localized in the trans-Golgi compartment and 
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mediates the cleavage of the above mentioned ENaC subunits that leads to release of an inhibitory 
tract thereby increasing channel open probability. In line with this notion, mutations of the furin 
cleavage site within α-ENaC inhibit channel activity and a significant reduction in Na+ current is 
observed in furin-deficient Chinese hamster ovary cells (Hughey et al. 2004). Notably, after 
trafficking to the cell surface ENaC may be further cleaved by several extracellular channel-
activating proteases (CAPs) (Vallet et al. 1997).  
Interestingly, both cleaved and non-cleaved ENaC subunits are found at the surface of cells 
expressing ENaC (Eaton et al. 2010). Probably, immature ENaCs (non-cleaved) work as a channel 
pool that can be activated by proteases on demand.  
Although there are many reports showing ENaC regulation via Po, it is believed that long-term 
modification of channel activity occurs by changes of ENaC cell surface abundance (Rossier 2002).  
1.6.2 Regulation of ENaC by apical membrane abundance 
Regulation of ENaC may also occur via altering cell surface expression of the channel by either 
influencing channel transport to the cell surface or by affecting endocytosis (Ismailov et al. 1995; 
Waldmann et al. 1995). Most of the synthetized subunits of ENaC remain as immature proteins in 
the endoplasmic reticulum (ER) or in pre-Golgi compartments and only a small portion of ENaC 
molecules reaches the plasma membrane where it participates in Na+ and water reabsorption. 
Mechanisms that regulate ENaC function at the cellular surface include control by hormones that 
either increase the number of new channel insertion or decrease ENaC retrieval and/or degradation 
(Eaton et al. 2010). 
Hormonal regulation 
Hormones such as aldosterone, vasopressin or insulin are known to regulate epithelial Na+ transport 
via affecting ENaC transcription or by post-transcriptional pathways. For example, increased 
ENaC trafficking to the cell surface mediated by aldosterone is mediated by translocation of the 
hormone to the nucleus where it induces ENaC transcription (May et al. 1997; Chen et al. 1999). 
Additionally, aldosterone may enhance transcription of serum and glucocorticoid-induced kinase 
1 (SGK1) that phosphorylates Nedd4-2 thereby affecting ENaC activity post-translationally 
(Bhalla et al. 2005; Snyder 2009).  
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Vasopressin modulates ENaC activity via Nedd4-2 phosphorylation driven by protein kinase A 
(PKA) that is activated in response to increased cAMP levels (Snyder 2009).  
In addition, ENaC open probability and cell surface abundance can be positively regulated by 
insulin (Baquero and Gilbertson 2011). The insulin-mediated signaling pathway includes the 
activation of phosphoinositol 3-kinase (PI3-kinase) leading to synthesis of PIP3 that affects ENaC 
via activation of SGK1. Thus, hormonally-regulated increase of ENaC expression results in higher 
channel cell surface abundance and greater activity. 
Ubiquitin-dependent endocytosis  
The activity of numerous small molecule, transporters and ion channels including ENaC can be 
reduced by endocytosis into intracellular compartments. Removal of ENaC from the plasma 
membrane requires addition of ubiquitin molecules to the NH2-terminus of the channel that act as 
a specific signal for channel internalization. The ubiquitin ligase, Nedd4-2 targets the ENaC 
complex for endocytosis and degradation by binding to the PY motif within the C-terminus of all 
ENaC subunits (Butterworth et al. 2007; Wiemuth et al. 2007; Kabra et al. 2008).  
The process of ubiquitination requires covalent attachment of ubiquitin (8.5 kDa protein) to lysine 
residues of ENaC and is mediated by the E3 ubiquitin ligase, Nedd4-2 that functions in conjugation 
with the ubiquitin-activating and -conjugating enzymes, E1 and E2, respectively. The first step of 
ubiquitination is the creation of a high-energy thioester bond between the glycine 76 residue of 
ubiquitin and a cysteine of the E1 enzyme. The ubiquitin from E1 is further relocated to the E2 
enzyme prior to the final step of ubiquitination in which, it is transferred by the E3 enzyme to the 
ε-amino group of a lysine located at the NH2-terminus of the targeted protein. The process in which 
a protein is bound by a single ubiquitin molecule is called monoubiquitination. Additionally, more 
ubiquitin molecules can be added to the first one resulting in a ubiquitin chain, a process termed 
polyubiquitination. A single ubiquitin can be also added to several lysine residues, this type of 
modification is known as multimonoubiquitination (Eaton et al. 2010; Vadász et al. 2012). 
ENaC can be ubiquitinated in various ways depending on the cell type or culture conditions. 
Although most studies indicate that ENaC subunits undergo mono or multimonoubiquitination 
(Wiemuth et al. 2007), some reports have shown polyubiquitination of the channel as well (Malik 
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et al. 2005; Butterworth 2010). It has been proposed that those ENaC subunits that are not 
transported to the cell surface are polyubiquitinated, while plasma membrane ENaCs undergo 
monoubiquitination (Rotin and Staub 2011). Despite of the differences in ENaC ubiquitination 
patterns, it is clear that mutation of key lysine molecules in the NH2-terminus prolongs channel 
half-life due to its retention at the apical surface (Hendron et al. 2002).  
Nedd4-2-driven ubiquitination of ENaC most likely occurs at the cell surface and results in 
internalization via clathrin-mediated pathways (Wang et al. 2006; Lu et al. 2007). The PY motif of 
COOH-terminus of ENaC overlaps with the tyrosine-based endocytosis domain Yxxϕ. This 
internalization motif mediates binding of the channel to the μ2 of adaptor protein-2 (AP-2), a 
clathrin adaptor that facilities entry of ENaC to clathrin-coated pits. Mutation of Yxxϕ of β-ENaC 
results in increased ENaC activity (Shimkets et al. 1997). A second possible pathway of ENaC 
endocytosis is an indirect interaction between ubiquitin and a ubiquitin-binding protein, such as 
epsin. It has been reported that co-expression of epsin together with Nedd4-2 decreases ENaC 
activity (Wiemuth et al. 2007). Following internalization, ENaC is designated for lysosomal or 
proteasomal degradation or recycled back to the plasma membrane (Butterworth et al. 2007). The 
pattern of ENaC ubiquitination determines the fate of the channel. For instance, it is supposed that 
proteosomal degradation occurs after ENaC polyubiquitination, while monoubiquitinated channels 
are degraded via lysosomes. Interestingly, some ubiquitinated ENaC molecules are held back from 
a degradation by deubiquitination, mediated by deubiquitinating enzymes (DUBs) such as 
ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (Butterworth 2010). 
Although it has been confirmed by many studies that ubiquitination generally initiates ENaC 
endocytosis and/or downregulation, there are some reports suggesting that ubiquitination may also 
activate the channel by promoting conformational changes in the extracellular loop leading to 
enhanced proteolytic cleavage (Rotin and Staub 2011). 
1.7 Characterization of ENaC/Nedd4-2 interaction 
The initial description of ENaC/Nedd4-2 interaction was presented in a two-hybrid screen study in 
which a truncated version of β-ENaC, which contained the PY motif was used as a bait (Staub et 
al. 1996). These studies revealed that the COOH-terminus of ENaC is critically important for 
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interactions with the WW domain of Nedd4-2 and shed light on the mechanism of channel 
trafficking from the plasma membrane.  
Additionally, studies in oocytes have shown that Nedd4-2-mediated decrease of ENaC cell surface 
abundance requires the presence of lysine residues localized at the N-terminus of the channel that 
are the target for ubiquitin modification (Hendron et al. 2002).  
Moreover, overexpression of Nedd4-2 significantly reduces ENaC-mediated Na+ transport, 
whereas Nedd4-2 knock-down increases ENaC expression (Snyder et al. 2004; Knight et al. 2006; 
Rotin and Staub 2012).  
The PY motif of ENaC  
Each ENaC subunit contains a conserved PY (PPPXY, P-proline, X-any amino acid and Y-
tyrosine) domain located at the COOH-terminus that serves as a Nedd4-2 binding site and allows 
possible ubiquitination. The first evidence showing that the ENaC/Nedd4-2 interaction is 
phisiologically significant was demonstrated in Madin-Darby canine kidney (MDCK) cells. In this  
study  co-expression of PY-mutants of ENaC (Liddle’s syndrome) resulted in increased channel 
activity compared to the wild type channels that was secondary to enhanced apical abundance of 
ENaC due to impaired channel ubiquitination (Staub et al. 1997).  
Structural features of Nedd4-2 
Nedd4 (neuronal precursor cell expressed developmentally down-regulated gene 4) proteins belong 
to the HECT family of E3 ligases (Rotin and Kumar 2009). There are eight members of the Nedd4 
ubiquitin ligase family in mammals. Among them, two structurally related proteins, Nedd4-1 and 
Nedd4-2 have been studied in detail. Nedd4-2, the isoform that is important for modulating ENaC 
trafficking, endocytosis and degradation contains a calcium phospholipid binding domain (C2) at 
the NH2-terminus, multiple WW segments (four in human, three in rodents) and a carboxyl HECT 
(homologous to E6-associated protein C-terminus) domain (Snyder 2005; Rotin and Staub 2012). 
The significance of the C2 domain in ENaC regulation has been shown in a study in MDCK cells 
in which increased cytosolic Ca2+ levels led to relocation of Nedd4-2 to the proximity of the cellular 
surface (where the E3 ligase interacts with ENaC), while deletion of the C2 domain blocked E3 
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ubiquitin ligase translocation (Plant et al. 1997). These findings showed a possible mechanism of 
ENaC regulation by Ca2+ however, so far no further studies have confirmed this hypothesis.  
The HECT domain is the catalytic domain of Nedd4-2 and thus, mutations of the cysteine residues 
within this region prevent inhibition of ENaC by Nedd4-2 (Abriel et al. 1999). It has been shown 
that the second and the third WW domains of Nedd4-2 interact with all ENaC subunits. However, 
binding of ENaC to the WW3 segment results in the greatest reduction in ENaC activity (Kamynina 
et al. 2001). A surface plasmon resonance study revealed that the binding of Nedd4-2 WW domains 
to β- and γ-ENaC has very slow dissociation, suggesting that the association between these proteins 
is almost irreversible (Asher et al. 2003).  
Phosphorylation as a key mechanism regulating interaction of ENaC and Nedd4-2 
Recent studies convincingly demonstrated that phosphorylation is a critical mechanism that 
regulates interaction of ENaC and Nedd4-2 and thus, ENaC-dependent Na+ transport (Debonneville 
et al. 2002; Carattino et al. 2005). The association between these two proteins can be regulated by 
kinases that mediate phosphorylation of either Nedd4-2 or ENaC at specific phospho-sites. For 
instance, PKA and SGK-1 have been shown to phosphorylate the same residue of Nedd4-2 
preventing ENaC ubiquitination and endocytosis (Bhalla et al. 2005). Recently, glucocorticoid-
induced leucine zipper protein-1 (GILZ-1) has been suggested as an important regulator of ENaC 
function (Soundararajan et al. 2010). This aldosterone-induced protein activates ENaC by 
recruiting SGK-1 and preventing ERK activation. Moreover, several other kinases are known to 
activate ENaC including IκB kinase-β that phosphorylates Nedd4-2 or casein kinase 2 that mediates 
phosphorylation of β- and γ-ENaC (Lebowitz et al. 2004).   
In contrast, some kinases are known to improve Nedd4-2-dependent ENaC ubiquitination and thus 
decrease channel activity. For example, ERK facilitates ENaC/Nedd4-2 interaction by direct 
phosphorylation of ENaC, thereby inhibiting the channel (Shi et al. 2002; Lazrak et al. 2012). 
Moreover, cellular stress leads to activation of AMPK that acts as cellular energy sensor. It has 
been reported that AMPK-driven down-regulation of ENaC is mediated by an increase in Nedd4-
2 activity probably through indirect phosphorylation of the E3 ligase (Bhalla et al. 2006; Almaça 
et al. 2009). Recently also JNK1 has been shown to be involved in phosphorylation of Nedd4-2. 
This phosphorylation leads to an increased Nedd4-2 activity promoting ubiquitination of ENaC-α 
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(Hallows et al. 2010). Eaton and co-workers demonstrated activation of PKC-δ in PKC-α knock-
out (KO) mice that leads to activation of ERK1/2 and increases endocytosis of ENaC via 
ubiquitination mediated by Nedd4–2 (Eaton et al. 2014).  
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2. Thesis objectives 
The major aim of the current work was to investigate whether hypercapnia modulates expression 
and function of ENaC in alveolar epithelial cells.  
Vectorial Na+ transport across the alveolar epithelium is driven by an interplay of ENaC and Na,K-
ATPase. Previous work from our group demonstrated that elevated CO2 levels impair alveolar 
epithelial function by inhibition of the Na,K-ATPase (Briva et al. 2007; Vadász et al. 2008; Vadász 
et al. 2012). The hypercapnic effects on the Na,K-ATPase have been shown to be dependent on 
intracellular calcium levels and activity of AMPK and PKC-ζ that by phosphorylation of the Na,K-
ATPase α-subunit promotes endocytosis of the sodium pump, thereby decreasing AFC (Vadász et 
al. 2008). Further studies have shown that downregulation of the Na,K-ATPase requires activation 
of JNK, a downstream target of AMPK (Vadász et al. 2012; Dada et al. 2015). Based on these 
findings, we hypothesized that hypercapnia may impair function of alveolar epithelial cells by 
regulating ENaC cell surface abundance.  
To study the effects of hypercapnia on ENaC functional expression, specific questions were 
formulated: 
I. Does hypercapnia alter cell surface expression of ENaC in alveolar epithelial cells? 
II. Does ubiquitination drive ENaC endocytosis initiated by elevated CO2 levels? And if so, 
which ENaC subunit(s) is (are) prone to be ubiquitinated? 
III. Does hypercapnia modify transepithelial Na+ transport by inducing ENaC cell surface 
retrieval? 
IV. Does the process of ENaC ubiquitination depend on the E3 ubiquitin ligase, Nedd4-2? 
V. Which key players are involved in ENaC regulation upon hypercapnic exposure and 
particularly which signaling events promote ENaC/Nedd4-2 interaction upon hypercapnia? 
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The possible signaling pathways involved in hypercapnia-induced ENaC downregulation are 
illustrated in Figure 2.1, which presents our working hypothesis.  
Figure 2.1 Proposed signaling pathway of CO2-regulated ENaC ubiquitination and 
endocytosis. CO2-induced polyubiquitination of β-ENaC and endocytosis of the α/β-ENaC 
complex are dependent on ERK1/2- and CaMKK-β-mediated activation of AMPK-α1. Active 
AMPK induces JNK1/2-dependent phosphorylation of Nedd4-2 at T899 residue, promoting E3 
ubiquitin ligase translocation to the cell membrane where it mediates ubiquitination of ENaC β-
subunit. Additionally, ERK1/2 via direct phosphorylation of β-ENaC at T615 residue facilitates 
ENaC/Nedd4-2 interaction. Ubiquitinated channels are internalized and either recycled back to the 
cellular surface or degraded in proteasomes or lysosomes. 
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3. Materials and Methods 
3.1 Instruments 
Table 3.1 List of electronic devices used in experiments. 
Device Supplier 
4D-Nucleofector System Lonza, Cologne, Germany 
BioPhotometer - Spectrophotometer BioRad, Munich, Germany 
Developer Curix 60 Processing Machine Agfa, Morstel, Belgium 
Electrophoresis and Blotting System BioRad, Munich, Germany 
HeraCell 150 - Cell Incubator Thermo Scientific, Dreieich, Germany 
Heraeus Fresco Micro Centrifuge Thermo Scientific, Dreieich, Germany 
Humidified Chamber BioSpherix Ltd. New York, USA 
Gel imaging system BioRad, Munich, Germany 
KNF Laboport vacuum pump flyer KNF, Freiburg, Germany 
LabChart software ADInstruments, Colorado Springs, USA 
Mettler H20T Precision Lab Scale Balance Mettler Toledo, Giessen, Germany 
Microcentrifuge, Ministar, Silverline VWR, Bruchsal, Germany 
Milli-Q Water Purification System Millipore, Schwalbach, Germany 
Mini-PROTEAN Tetra Cell BioRad, Munich, Germany 
Msc-Advantage- Smart flow Thermo Scientific, Dreieich, Germany 
NanoDrop 1000 Thermo Scientific, Dreieich, Germany 
Neubauer Improved Cell Counting 
Chamber 
Labor Optik, Friedrichsdorf, Germany 
pH-Meter 766 Knick, Berlin, Germany 
Pipetes Gilson, Limburg-Offheim, Germany 
Plymax 1040-Waving Platform Shaker Heidolph, Schwabach, Germany 
PowerPac Basic Power Supply BioRad, Munich, Germany 
PowerLab 8/35 ADInstruments, Colorado Springs, USA 
RapidLab Blood Gas Analyzer Siemens, Erlangen, Germany 
Thermocycler Biometra GmbH, Göttingen, Germany 
Thermomixer Eppendorf, Hamburg, Germany 
Transblot SD Semi-Dry Transfer Cell BioRad, Munich, Germany 
Ussing chamber equipment: 
(Heat Block, Snapwell Chambers, 
Ag/AgCl Electrodes, Electrode Lead Sets, 
voltage/current Clamp) 
Physiologic Instruments, San Diego, USA 
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3.2 Plasmids 
All plasmids used in the studies are listed in Table 3.2. Vectors expressing ENaC subunits were 
generated as described previously (Buchbinder 2013; Gwoździńska et al. 2017). pRK5-HA-
ubiquitin plasmid was obtained from Ted Dawson [Addgene #17608], (Lim 2005). pCI-
HANEDD4L plasmid was a gift from Joan Massague [Addgene #27000], (Gao et al. 2009). pCI-
HANEDD4L_T899A contained mutation in T899 residue was created using Quick Change 
Mutagenesis Kit (described in section 3.21). The mutated β-ENaC lacking T615 (βΔT615ENaC) was 
created by Gibson assembly technique (described in Section 3.22).  
Table 3.2 List of plasmids employed in cell transfection experiments. 
Vector backbone Gene insert Resistance 
pcDNA3.1V5/His (β-ENaC-V5) β-subunit of human epithelial sodium channel 
NM_000336.2. 
Ampicillin 
pcDNA3.1V5/His_ ΔT615 (βΔT615-ENaC-
V5) 
β-subunit of human epithelial sodium channel with 
T615 deletion. 
Ampicillin 
pCI-HANEDD4L Human Nedd4L (Nedd4-2), E3 ubiquitin protein 
ligase 
Ampicillin 
pCI-HANEDD4L_T899A Human Nedd4L (Nedd4-2), E3 ubiquitin protein 
ligase with point mutation T899A 
Ampicillin 
pCMV-HA-C (HA-γ-ENaC-myc) γ-subunit of human epithelial sodium channel 
NM_001039 
Kanamycin 
pEYFP-C1 (eYFP-α-ENaC-Flag) α-subunit of human epithelial sodium channel 
NM_001038 
Kanamycin 
pRK5-HA-Ubiquitin Human ubiquitin Ampicillin 
3.3 siRNAs 
Table 3.3 List of siRNAs employed in knock-down studies. 
siRNA Concentration [nM] Supplier 
AMPK-α1 (sc-29673) 50 Santa Cruz Biotechnology 
Nedd4-L (sc-75894) 100 Santa Cruz Biotechnology 
Negative control (SR-
CL000-005) 
50-100 Eurogentec 
Materials and Methods 
 
37 
 
3.4 Inhibitors 
Table 3.4 List of inhibitors employed in the studies. 
Compound Vehicle Concentration 
Amiloride, ENaC inhibitor DMSO 10 μM 
Compound C, AMPK inhibitor DMSO 20 μM 
Complete, proteases inhibitor H2O 1 tablet/1ml 
SP600125, JNK inhibitor DMSO 25 μM 
STO609, CaMKK-β inhibitor DMSO 20 μg/ml 
U0126, MEK-1 and MEK-2 inhibitor DMSO 10 μM 
3.5 Antibodies 
Table 3.5 Antibodies used in the studies. 
Antibody name (cat. number) Species  Dilution Supplier 
Anti-GFP (11814460001) mouse 1:1000 Roche 
Anti-V5 (V8137-2mg) rabbit 1:50 (IP) Sigma-Aldrich 
Anti-V5 (R960-25) mouse 1:1000 Invitrogen 
Anti-Transferrin Receptor (13-6800) mouse 1:1000 Invitrogen 
Anti-HA.11 (MMS-101P) mouse 1:750 Covance 
Anti- β-actin (A20066-2ml) rabbit 1:1000 Sigma-Aldrich  
Anti-Nedd4-L (sc85081) rabbit 1:1000 Santa Cruz  
Phospho-AMPK-α1 (Thr172) (#4188) rabbit 1:1000 Cell Signaling 
Anti-AMPK-α1 (sc2793) mouse 1:1000 Cell Signaling 
Phospho-p44/42 MAPK (ERK1/2) (Thr202/Tyr204) (#9106) mouse 1:1000 Cell Signaling 
p44/42 MAPK (ERK1/2) (#9102) rabbit 1:1000 Cell Signaling 
Phospho-c-Jun (Ser63) (#9261) rabbit 1:750 Cell Signaling 
Anti-JNK (ab179461) rabbit 1:1000 Abcam  
Alexa Fluor 488 (A-11008)  rabbit 1.500 Thermo Scientific 
Phospho-anti SCNN1B(T615) (ab79172) rabbit 1:750 Abcam 
IgG, HRP linked (31450) mouse 1:5000 Thermo Scientific 
IgG, HRP linked (7074S) rabbit 1:5000 Cell Signaling 
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3.6 Cell lines and bacterial strains 
Cell lines:  
Isolation of primary rat alveolar epithelial type II (ATII) cells were performed according to the 
legal regulations of the German Animal Welfare Act and were approved by the regional authorities 
of the State of Hessen.  
 
• Primary rat ATII cells were isolated as described previously (Vadász et al. 2008; 
Buchäckert et al. 2012).  
• Human adenocarcinoma alveolar epithelial cell line (A549) were purchased from the 
American Type Culture Collection, (ATCC-CCL-185)  
• Human airways epithelial cells (H441) were purchased from the American Type Culture 
Collection, (ATCC-HTB-174) in the 55th passage.  
Bacterial strains: 
• E. coli DH5α (New England Biolabs, Ipswich, USA) was used for DNA transformation and 
plasmid isolation. 
• XL1-Blue super competent cells were provided with Quick Change Mutagenesis Kit 
(Stratagene, La Jolla, USA) and were used for site directed mutagenesis experiments. 
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3.7 Culture media and growth conditions of eukaryotic cells 
All cell types were maintained in a humidified atmosphere of 5% CO2 and 95% air at 37 °C (unless 
stated otherwise). The cells were subcultured when 80% of confluency was achieved. After 
removing media, cells were washed with sterile phosphate buffered saline (PBS; Life Technology, 
Darmstadt, Germany), incubated in 1 ml of trypsin solution (Life Technology) for 5 min and re-
suspended in culture media. The culture medium was replaced every 48 h.  
ATII cells were grown on 60 mm culture dishes (Sarstedt, Nümbrecht, Germany) in 4 ml of culture 
media containing high glucose (4,5 g/L) Dulbecco’s Modified Eagle’s media (DMEM; Life 
Technology) supplemented with 10% fetal bovine serum (FBS; PAA Laboratories, Egelsbach, 
Germany), 100 Uml-1 penicillin and 100 μgml-1 streptomycin (both from PAN-Biotech, Aidenbach, 
Germany). 24 h after isolation cells were used in experiments. After nucleofection, ATII cells were 
seeded on permeable membrane supports (BD Falcon, Heidelberg, Germany) under liquid/liquid 
conditions in full DMEM media for 18 h and then were used for analysis.  
A549 cells were grown in the same culture conditions as described for ATII cells. Cells were used 
only between passage 4 and 13. Transfected cells were seeded on 6-well tissue culture plates (~2x 
106 cells/well) (BD Falcon). 
H441 cells were cultured in Roswell Park Memorial Institute Media (RPMI 1640; Life 
Technology) supplemented with 10% FBS, 1% insulin-transferrin-sodium selenite (ITS) and 1 mM 
sodium pyruvate (Sigma Aldrich), 100 Uml-1 penicillin and 100 μgml-1 streptomycin.  
For Ussing chamber recordings, H441 cells were re-suspended in culture media and seeded on the 
transwell clear inserts [12 mm diameter, 0.4 µm pore size] (Corning, Sigma Aldrich) at a density 
of 500,000 cells/cm2. In the first 24 h cells were cultured under liquid/liquid conditions after which 
the fluid from the apical compartment was aspirated and 100 nM dexamethasone (Sigma Aldrich) 
was added to the basolateral side. Cells were kept under air/liquid conditions for the next 6 days 
and were then used for transepithelial ion transport studies.  
Materials and Methods 
 
40 
 
3.8 Transfection of eukaryotic cells 
The amount of total ENaC protein expressed in epithelial cells is relatively large compared to the 
number of the channels located at the cell membrane (functional expression). It has been estimated 
that approximately 10–30% of the channel is located outside of the endoplasmatic reticulum (ER) 
in native cells, whereas in transfected cells only 1-2% of total ENaC can be found at the cell surface 
(Hughey et al. 2004; Eaton et al. 2010). To improve the expression of ENaC in the alveolar 
epithelial cells and to increase the recognition signal for the antibodies, plasmids encoding ENaC 
subunits were delivered to the cells by applying nucleofection (Lonza, Cologne, Germany). 
Nucleofection creates pores in cellular and nuclear membranes by using electrical pulses thus 
representing an alternative to viral and phospholipid-based methods of DNA delivery. As we have 
previously reported, this method allows transport of oligonucleotides to slow- or non-proliferating 
cells like ATII cells with high viability and efficiency (Grzesik et al. 2013). 
3.8.1 Nucleofection of ATII cells 
ATII cells were washed 3 times with PBS, trypsinized and counted one day after isolation. The 
required number of cells (4 x 106 cells per reaction) was centrifuged (90 g, 10 min 20 ᵒC). The 
pellets were suspended in 100 µl of P3 nucleofection solution (specific for primary cell lines and 
provided with the kit) mixed with DNA, placed in a cuvette and pulsed with the cell-type-specific 
nucleofection program. Transfected cells were cultured on transwell supports in DMEM with 4.5 
g/L glucose supplemented with 10% FBS (v/v) and 1% penicillin-streptomycin mix (v/v).  
3.8.2 Nucleofection of A549 cells 
A549 cells were plated on culture dishes and reached approximately 60% confluency on the day 
of transfection. After washing with PBS and trypsinization, cells were counted and re-suspended 
in 100 µl SF solution (provided with the kit). Next, A549 cells were mixed with 4-6 µg of the 
desired DNA(s) and transfected in nucleofection cuvettes. After 10 min of incubation the 
transfected cells were diluted 1:1 in cultured media and plated (~2 x 106 cells per 35 mm dish). 
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3.8.3 Transfection with siRNA 
In some studies, A549 cells were transfected with siRNA using Lipofectamine RNAiMAX 
(Invitrogen, Waltham, USA) 24 h before nucleofection with ENaC plasmids.  
A549 cells were transfected with siRNA (concentrations are specified in Table 3.3) and 
Lipofectamine RNAiMax (7 µl per reaction), both diluted in Opti-MEM (Life Technology). The 
diluted siRNA was added to the diluted Lipofectamine RNAiMax after 5 min of preincubation at 
the room temperature. The siRNA-lipid mix was incubated for additional 20 min at the same 
temperature and then added to the cells. After 24 h, cells were collected and transfected with ENaC 
plasmids by nucleofection.  
3.9 Hypercapnia treatment 
To investigate effects of hypercapnia on ENaC expression and function, cells were treated with 40 
mmHg (normocapnia, Ctrl) or 120 mmHg CO2 (hypercapnia, CO2) for various times (specified 
along the thesis). The normocapnic and hypercapnic media were prepared in 4.5 g/L glucose 
DMEM and F12 supplement (Thermo Scientific, Dreieich, Germany). To keep the pH constant 
(7.4) at 40 mmHg or 120 mmHg CO2 the buffering capacity of the media was altered by changing 
its initial pH with Tris base. The desired CO2 levels were achieved by equilibrating the solutions 
overnight in a humidified chamber. In the chamber, cells were treated with a pCO2 of 120 mmHg 
while maintaining 21% O2 balanced with N2. Before and after treatment with CO2, the level of CO2 
and pH were controlled by using a Rapidlab blood gas analyzer.  
Table 3.6 Composition of normocapnic and hypercapnic media. 
Supplement Normocapnic 
media [ml] 
Hypercapnic 
media [ml] 
DMEM media with FBS and 
penicillin-streptomycin mix  
3  3  
Ham´s F-12 medium 1  1  
Tris base solution 0.5 M (pH 7.4) 0.5  - 
Tris base solution 0.5 M (pH 11) - 0.5  
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3.10 Biotinylation of cell surface proteins 
To analyze the effects of hypercapnia on ENaC expression at the plasma membrane, cells were 
washed with PBS containing Mg2+ and Ca2+ and incubated with membrane impermeable biotin 
(Pierce Biotechnology, Waltham, USA) dissolved in PBS (1 mg/ml) for 20 min. After 
biotinylation, excess biotin was removed through three 10 min washes with 100 mM glycine 
(Sigma Aldrich). Next, cells were rinsed two further times with ice-cold PBS and lysed with lysis 
buffer (50 mM HEPES, 150 mM NaCl, 1 mM EGTA, 10% Glycerol, 1% TritonX100) containing 
a protease inhibitor (Complete; Sigma Aldrich) for 20 min. Later, cells were scraped and the 
collected lysates were centrifuged for 10 min at 10000 rpm at 4 ᵒC. Protein concentrations were 
quantified using Quick-Start Bradford-Assay (BioRad), according to the instructions of the 
manufacturer. Protein absorbance was measured using a Biophotometer. 120 µg protein was 
incubated with streptavidin-agarose beads (Pierce Biotechnology) overnight at 16 rpm, 4 °C. On 
the next day beads were washed with buffer A, B, C and 10 mM Tris (Table 3.7) 
Table 3.7 Buffers employed for washing of agarose beads.  
Buffer A Buffer B Buffer C: 
150 mM NaCl 500 mM NaCl 500 mM NaCl 
50 mM Tris pH 7.4 20 mM Tris pH 7.4 20 mM Tris pH 7.4 
5 mM EDTA 5 mM EDTA 0.2% BSA 
To elute biotin-labeled proteins, resins were boiled in 2X Laemmli sample buffer containing 10% 
β-mercaptoethanol and 20 mM DTT at 98 °C for 10 min. Proteins were analyzed by SDS-PAGE 
and western blotting.  
3.11 SDS-PAGE and western blotting  
Western blot experiments were performed to analyze the effects of hypercapnia on ENaC 
expression and to determine the phosphorylation status of proteins involved in the hypercapnic 
signaling pathway.  
50-120 µg protein was combined with 2X Laemmli sample buffer and heated to 98 ᵒC for 10 min 
prior to loading into the gel. Blots were run in 8% polyacrylamide gels (Roth, Karslruhe, Germany) 
(Table 3.8). Electrophoresis was carried out in running buffer (Table 3.9) at 100-120 V for 1.5 h. 
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Table 3.8. SDS-PAGE gel composition.  
8% separating gel (20 ml) Volume [ml] 5% stacking gel (10 ml) Volume [ml] 
H2O 9.3 H2O 6.8 
1.5 M Tris pH 8.8 5.3 1.5 M Tris pH 6.8 1.3 
30% Acrylamide/Bis 5.0 30% Acrylamide/Bis 1.7 
10% SDS 0.2 10% SDS 0.1 
10% APS 0.2 10% APS 0.01 
TEMED 0.012 TEMED 0.001 
 
Protein transfer to a nitrocellulose membrane (BioRad) was performed using the semi-dry method 
at 400 mA for 60 min in transfer buffer (Table 3.9). The membranes were blocked with 5% (m/v) 
fat-free dried milk (Sigma Aldrich) for 1 h and incubated with primary antibody overnight at 4 ᵒC.  
Table 3.9 Running and transfer buffers. 
Running Buffer (1L) Amount [g] Transfer Buffer (1L) Amount  
Tris 30 Tris 2.45 g 
Glycine 144 Glycine 12.2 g 
SDS 100 Methanol 20% [v/v] 
 
On the next day, membranes were washed 3 times with washing buffer (T-TBS) (Table 3.10) and 
the secondary antibody conjugated to horseradish peroxidase (HRP) was added for 1 h. Unspecific 
antibody binding was reduced by 3 times washing with T-TBS after removing the secondary 
antibody. Next, membranes were incubated with a SuperSignal West Pico or a Femto 
Chemiluminescent Substrate detection kit (Thermo Scientific), films were developed, and the 
density of proteins was quantified using the ImageJ software (National Institutes of Health, 
Bethesda, Maryland, USA). To reprobe the blots, membranes were treated with stripping buffer 
(Table 3.10) for 50 min at the room temperature, blocked again in 5% milk and another antibody 
was added.  
Table 3.10 Washing and stripping buffers. 
Washing Buffer (TBS-T) (1L) Amount Striping Buffer (25 ml) Volume [ml] 
Tris 2.45 g 1M Glycine 2.5 
NaCl 8.0 g  H20 22.5 
Tween 20 1 ml 37% HCl 0.25 
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3.12 Ubiquitination experiments 
To assess the level of ENaC ubiquitination, A549 cells were transfected with ENaC plasmids (2 μg 
of each) and HA-ubiquitin (3 μg). In some studies, cells were co-transfected with a plasmid 
encoding HA-Nedd4-2 (wild type or T899A mutant, 2 μg) or a siRNA against AMPK-α1 or Nedd4-
2 (or scrambled siRNA). After transfection cells were exposed to normocapnic (Ctrl; 40 mmHg of 
CO2) or hypercapnic (CO2; 120 mmHg of CO2) media for 15-30 min and lysed on ice in lysis 
buffer. Proteins were resolved on a 8% polyacrylamide gel. The immunoblots were performed with 
anti-GFP, anti-V5 or anti-HA antibodies to detect α-, β- or γ-ENaC, respectively. X-ray films were 
overexposed to detect ENaC ubiquitin conjugates, which represent only a minor fraction of the 
total ENaC proteins. An increase in ENaC ubiquitination due to elevation in CO2 levels was further 
confirmed by co-immunoprecipitation described in paragraph 3.14. 
3.13 Phosphorylation studies 
For studying phosphorylation of specific kinases implicated in the hypercapnia-induced ENaC 
downregulation, cells were exposed to normal (Ctrl; 40 mmHg of CO2) or elevated (CO2; 120 
mmHg of CO2) CO2 levels for different time intervals. After treatment, cells were washed with 
PBS twice and were lysed on ice in lysis buffer. Next, samples having equal amount of protein 
were resuspended in 2X Laemmli sample buffer and heated to 98 ᵒC for 10 min prior to loading 
into the gel. The proteins were subjected to western blot analysis with first phospho-specific 
antibodies and then blots were reprobed with an antibody against the protein of interest to detect 
total protein levels. Phospho and total protein levels were measured and quantified using the 
ImageJ software.  
3.14 Co-Immunoprecipitation 
To investigate protein-protein interaction co-immunoprecipitation (co-IP) was carried out. The first 
set of co-IP experiments was performed to detect ubiquitinated ENaC isoforms. To this end, A549 
cells were nucleofected with β-ENaC and HA-ubiquitin and exposed to normocapnic (Ctrl; 40 
mmHg of CO2) or hypercapnic (CO2; 120 mmHg of CO2) media for 30 min. Next, cells were 
washed three times with PBS and lysed in lysis buffer for 20 min. 750 μg protein was precleared 
with A/G agarose beads (Santa Cruz, Heidelberg, Germany). Precleared lysates were rotated with 
Materials and Methods 
 
45 
 
anti-V5 antibodies overnight at 4 °C. Then, antigen-antibody complexes were immunoprecipitated 
by adding 80 μl of A/G agarose beads, rotated overnight at 4 °C and washed 4 times with lysis 
buffer containing protease inhibitor, Complete. Agarose beads were combined with 2X Laemmli 
sample buffer and heated to 98 ᵒC for 10 min prior to loading on the gel. β-ENaC ubiquitinated 
isoforms were detected with anti-HA antibody.  
To elucidate the role of Nedd4-2 in β-ENaC ubiquitination, immunoprecipitation of β-ENaC was 
performed. A549 cells were transfected with plasmids coding human β-ENaC-V5 and human HA-
Nedd4-2 and were exposed to normocapnic or hypercapnic media for 30 min. To confirm the β-
ENaC–Nedd4-2 interaction, precleared lysates were incubated with rabbit anti-V5 antibody 
overnight, next the antibody-antigen complexes were combined with A/G agarose beads. Western 
blot was first probed with mouse anti-HA antibody to detect Nedd4-2 and then reprobed with anti-
V5 antibody to confirm the presence of β-ENaC in the precipitated complex. Anti-rabbit IgG was 
used as negative control (Sigma Aldrich). 
3.15 Immunofluorescence microscopy 
Immunofluorescent staining was performed to study membrane expression of α-ENaC. A549 cells 
were treated with normocapnia (“Ctrl” 40 mmHg of CO2) or hypercapnia (“CO2” 120 mmHg of 
CO2) for 30 min and then were fixed by incubation with 4% paraformaldehyde for 10 min (Thermo 
Scientific). A549 cells were washed three times with PBS and permeabilized with 0.1% saponin 
(Sigma Aldrich) for 5 min. Unspecific binding was blocked by incubation with 5% BSA (PAA 
Laboratories) diluted in PBS for 1 h at room temperature. After overnight incubation with a 1:50 
dilution of the anti-α-ENaC antibody, cells were washed three times with PBS and incubated for 1 
hour at room temperature with 1:500 dilution of Alexa Fluor-488 secondary antibody. Stained cells 
were washed with PBS three times and 3 µl of ProLong Gold with DAPI (Thermo Scientific) were 
applied. Images were obtained using a fluorescent microscope (Leica DMIL), a digital camera 
(Leica DFC 420C) and the software Leica application suite 330. 
3.16 Real time PCR 
Total RNA was extracted form A549 cells after 30 min exposure to normocapnic (“Ctrl” 40 mmHg 
of CO2) or hypercapnic (“CO2” 120 mmHg of CO2) solutions, using the standard protocol of 
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RNeasy-Kit (Qiagen, Hilden, Netherlands). The RNA was diluted in RNA-free water and the 
concentration was determined by NanoDrop 1000. RNA samples were kept at -70 °C. 1 µg of total 
RNA was used to generate cDNA using an iScript cDNA synthesis kit (BioRad). The reaction mix 
is showed in Table 3.11.  
Table 3.11Mix for cDNA synthesis. 
Component Volume [µl] 
5x Reaction buffer 4  
RNA 1µg x 
Reverse transcriptase 1  
H2O to 20  
Finally, the cDNA was diluted 1:5 or 1:10 and qRT-PCR was performed with Syber Green Master 
Mix (BioRad) using cycle conditions showed below: 
 
 
 
α-ENaC and β-ENaC mRNA expression levels were normalized to human glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) as an endogenous control. The primer sequences used for real-
time analysis were synthesized by Eurofins Genomic (Ebersberg, Germany) and are shown in Table 
3.12. 
Table 3.12 Primer sequences for real-time PCR. 
Targets Sequence (5’->3’) 
αENaC Fwd ACTTCAGCTACCCCGTCAGC 
Rev GAGCGTCTGCTCTGTGATGC 
βENaC Fwd GCACCGTGAATGGTTCTGAG 
Rev CGGATCATGTGGTCTTGGAA 
GAPDH  Fwd AGCACCAGGTGGTCTCCTCT 
Rev CTCTTGTGCTCTTGCTGGGG 
Initial Denaturation 60 s 95°C  
Denaturation 60 s 95°C 
   x40 
Primer annealing and elongation 30 s 55°C 
Cool down - 4°C  
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3.17 Electrophysiology 
To investigate the effects of elevated CO2 levels on transepithelial Na
+ transport, Ussing chamber 
experiments were performed on H441 cells. For these measurements, cells were grown on clear 
inserts [12 mm diameter with 0.4 µm pore size] (Corning) in the presence of 100 nM 
dexamethasone until a tight epithelium was formed. Next, the monolayers were treated with 
normocapnic (“Ctrl” 40 mmHg of CO2) or hypercapnic (“CO2” 120 mmHg of CO2) media for 30 
min and mounted into a Ussing chamber filled with Kreb’s solution (117 mM NaCl, 2.7 mM KCl, 
1.2 mM MgSO4, 1.2 mM KH2PO4, 25 mM NaHCO3, 1.8 mM CaCl2, 11mM Glucose) at 37 °C. The 
chambers were attached to a voltage clamp amplifier through Ag/AgCl electrodes filled with 3M 
KCl-agar (Sigma Aldrich). Short circuit currents (Isc) were measured and recorded using LabChart 
version 8.  
To calculate the amount of amiloride-sensitive (Iamil-sens) current in H441 monolayers, Isc was 
measured before and after incubation with 10 µM amiloride (Sigma Aldrich). At least three filters, 
with different cell passages, were used for the experiments.  
3.18 Bacterial culture media and growth conditions  
Bacteria were grown in Luria–Bertani (LB) media (Sigma Aldrich) overnight at 180 rpm, at 37 °C 
in the presence of proper antibiotics (Table 3.5). The antibiotic concentrations were as follows: 
ampicillin (100 µg/mL) and kanamycin (30 µg/mL) (both, Sigma Aldrich). For longer storage 
glycerol stocks were prepared from the overnight culture mixed with 50% of glycerol (Sigma 
Aldrich). Strains were stored at 80 °C in cryovials.  
3.19 Transformation of competent cells 
Preparation of competent cells: 
To prepare competent cells, fresh, overnight bacterial culture (E. coli-DH5α) was grown till OD600 
of 0.4. Bacteria were kept on ice for 20 min prior to centrifugation at 3000 g at 4 °C for 10 min. 
Pellets were gently re-suspended in 17 ml cold CCMB80 buffer: 80 mM CaCl2, 20 mM MnCl2, 10 
mM MgCl2, and 10 mM KOAc, 10% Glycerol and incubated additional 20 min on ice. Bacteria 
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were centrifuged as described previously and pellets were re-suspended in 4.2 ml CCMB80 buffer. 
Chemically competent cells were aliquoted, frozen and stored at -80 °C.  
Transformation: 
The chemically competent bacteria were transformed with plasmids by heat shock method 
(Sambrook and Russell 2001). Briefly, competent cells were mixed with 100 ng of DNA and 
incubated on ice for 30 min. Then mixture of cells and DNA were placed into water bath at 42 °C 
for 45 s and placed again on ice for 2 additional minutes. After this time 450 µl of SOC medium 
(Invitrogen, Darmstadt, Germany) was added and cells were shook at 250 rpm, at 37 °C for 1.5 h. 
Transformed bacteria were cultured on LB agar plates containing a proper antibiotic and incubated 
overnight at 37 °C. 
3.20 DNA isolation and purification 
Plasmids were isolated using plasmid Maxi kit (Qiagen) according to the standard protocol. All 
buffers were provided with the kit. Briefly, 200 ml of overnight cultured bacteria containing the 
desired DNA were centrifuged at 6000 rpm for 15 min at 4°C. The medium was removed, and the 
pellets were re-suspended in 10 ml of resuspension buffer containing RNase A (P1). Lysis was 
performed by addition of 10 ml SDS-alkaline buffer (P2). After 5 min of incubation at room 
temperature, 10 ml of neutralization buffer (P3) was added. The cell lysates were incubated for 20 
min on ice prior to centrifugation at 20000 rpm at 4 °C for 30 min. QIA filter columns were washed 
with 10 ml equilibration buffer (QBT) and the supernatant from the previous step was loaded onto 
the column. After washing with 60 ml of wash buffer (QC), DNA was eluted with 15 ml of elution 
buffer (QF) and precipitated with 10.5 ml cold isopropanol. After centrifugation at 15000 rpm for 
30 min, DNA pellets were washed with 70% ethanol (Otto-Fischer GmbH, Saarbrücken, Germany) 
centrifuged again (15000 rpm at 4 °C for 5 min) and dried on air. Finally, DNA was dissolved in 
100 µl TE buffer and plasmid concentration was measured by NanoDrop 1000.  
3.21 Site-directed mutagenesis 
Site-directed mutagenesis was performed to generate human Nedd4-2 mutant (T899A) encoded in 
pCI-HANEDD4L plasmid. The specific substitution was performed using Quick-Change Site-
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Directed Mutagenesis kit (Stratagene, La Jolla, USA) in accordance with the manufacturer’s 
instructions. The reaction is based on amplification of a plasmid coding the protein of interest with 
high-fidelity DNA polymerase (PfuUltra) and primers containing the desired mutation in the 
sequence (Table 3.13). The cycle parameters used in experiment are shown below: 
 
 
 
 
 
Table 3.13 Primer sequences for SDM 
Primers Sequence (5’->3’) 
NeddT899A_fwd ACTGCAGTTTGTCGCAGGGACATCG CGAG 
NeddT899A_rev CTCGCGATGTCCCTGCGACAAACTGCAGT 
After PCR amplification, the product of the reaction was treated with 0.5 µl DpnI (provided with 
the kit) at 37 °C for 1 h to remove methylated, parental DNA. DpnI-treated DNA and control 
plasmid were transformed to ultra-competent cells (XL10-Gold) by the heat shock method as 
described in Section 3.19 and plated on LB-agar plates containing ampicillin (100 µg/mL). The 
positive colonies were subcultured into LB media and grown overnight at 37 °C. DNA was isolated 
and sequenced to confirm the presence of the desired mutation as described in Section 3.24.  
3.22 Gibson assembly 
The extracellular signal-regulated kinase (ERK) has been reported as a potential regulator of 
ENaC/Nedd4-2 interaction (Shi et al. 2002). To study the role of ERK1/2-dependent 
phosphorylation of β-ENaC, the codon encoding the T615 residue was deleted from β-ENaC-
positive pcDNA 3.1V5/His plasmid by using the Gibson assembly method. This technique allows 
assembly of multiple DNA fragments in a single reaction. Briefly, plasmid amplification was 
carried out in a way that resulted in PCR products that did not include the T615 residue (β-ΔT615) 
using two sets of primers shown in Table 3.14. The two amplified fragments were assembled 
together using Gibson master mix according to the manufacturer's protocol (New England Biolabs, 
Frankfurt, Germany). Following the transformation of the assembled plasmid to highly competent 
Initial Denaturation 60 s 95 °C  
Denaturation 50 s 95 °C 
  x18 Primer annealing  50 s 60 °C 
Elongation 7 min 68 °C  
Cool down - 4 °C  
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E. coli DH5α, cells were plated on 100 mg/L ampicillin LB-agar plates and incubated overnight at 
37 ᵒC. The grown colonies were collected and screened by sequencing to confirm the presence of 
the desired mutation. 
Table 3.14 Primer sequences for Gibson assembly experiments. 
Primers: Sequence (5’->3’) 
βENaCΔT615_Frg1_fwd GCCCTGCCCATCCCAGGCCCGCCCCCCAACTATGAC 
βENaCΔT615_Frg1_rev ATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATG 
βENaC ΔT615_Frg2_fwd AGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGC 
βENaC ΔT615_Frg2_rev GTCATAGTTGGGGGGCGGGCCTGGGATGGGCAGGGC 
3.23 Agarose gel 
1% agarose gels was prepared according to the standard procedure (Sambrook and Russell 2001) 
to assess the size of PCR products. The DNA was mixed with 5X loading buffer prior to loading 
into the gel and electrophoresis was performed in 1x TAE buffer (4.8 g Tris, 100 ml EDTA (pH 
8), 57 ml acetic acid, supplemented with 5 mg/L of ethidium bromide) at 150 V, 250 mA for 1 h. 
3.24 DNA sequencing 
DNA sequencing was performed by SeqLab Company (Göttingen, Germany). To confirm the 
mutation in Nedd4-2, the reaction was performed with EBV-rev primers using Sanger Cycle 
Sequencing/Capillary Electrophoresis. Deletion of T615 of β-ENaC was proven by DNA 
sequencing using BGH-rev primer. The sequences were compared using the bioinformatics tool 
BLAST. 
3.25 Data analysis and statistic 
All experiments were performed at least in triplicates using cells from different passages. Data 
were statistically analyzed using one-way analysis of variance (ANOVA) followed by a multiple 
comparison with Dunnet test and are presented as mean ± standard error of the means (SEM). P 
values of less than 0.05 were considered statistically significant. For the analysis and data 
presentation Graph Pad prism 6 (GraphPad software, San Diego, CA) was used. 
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4. Results 
Primary ATII cell cultures play an essential role in studies focusing on alveolar epithelial barrier 
function and transepithelial ion transport. Thus, our key studies were performed in this cell type. 
However, due to the high complexity of some assays and the need of co-transfection with up to 
four constructs, which is extremely challenging in this cell type, most of the studies were performed 
in human A549 cells that are regularly used as a substitute for pneumocytes in vitro (Sporty et al. 
2008) and have been shown to express all elements of the Na+ transport machinery similarly to 
primary pneumocytes (Matalon et al. 2015). 
While A549 cells express ENaC and the Na,K-ATPase, this cell line does not form tight polarized 
monolayers that leads to relatively low transepithelial electrical resistance (TEER) (Elbert et al. 
1999). In contrast, several studies reported that the human H441 cell line is capable of forming 
physiologically relevant TEER when grown on the permeable supports (Hermanns et al. 2004; 
Neuhaus et al. 2012). Moreover, these cells express markers characteristic for human ATII and are 
a well-established model for pulmonary sodium transport  (Salomon et al. 2014), thus the impact 
of high CO2 levels on transepithelial Na
+ transport was studied using H441 cells.   
To study the effects of hypercapnia on ENaC expression and function, cells were treated with 120 
mmHg of CO2. Such high CO2 concentrations in blood and tissues may occur in patients with 
pulmonary diseases, including patients with ARDS who require lung-protective mechanical 
ventilation (Vadász et al. 2012; Bellani et al. 2016). However, the increase in CO2 concentrations 
in turn, decreases pH. In order to differentiate between the effects of elevated CO2 levels and the 
associated acidosis, the level of extracellular pH (pHe) was maintained at 7.4 in all experiments. 
Importantly, it has been previously reported that treatment of cells with elevated CO2 
concentrations at a pHe of 7.4 causes only a minor and temporary decrease in intracellular pH (pHi) 
that rapidly returns to baseline (Briva et al. 2007). 
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4.1 Hypercapnia alters ENaC expression at the cell surface of alveolar epithelial cells 
ENaC-mediated Na+ transport across the alveolar epithelium controls alveolar fluid homeostasis 
and provides a thin diffusion barrier for efficient gas exchange (Matthay et al. 2002). Since AFC 
depends on optimal function of ENaC (Canessa et al. 1994; Voilley et al. 1994; Matthay and 
Zemans 2011; Fronius et al. 2012), the elevated CO2-induced changes in channel activity (which 
in part depends on the abundance of these channels at the cell surface) may lead to impaired 
resolution of pulmonary edema in patients with ARDS. 
Although hypercapnia-mediated downregulation of the Na,K-ATPase has been demonstrated 
previously (Briva et al. 2007; Vadász et al. 2008; Welch et al. 2010; Vadász, et al. 2012), the 
influence of elevated CO2 levels on ENaC regulation remained to be elucidated.  
The DNA constructs expressing human α-, β- and γ-ENaC were generated in our laboratory as 
described previously (Buchbinder 2013; Gwoździńska et al. 2017). Anti-GFP antibodies 
recognized YFP- and FLAG-tagged α-ENaC construct and revealed a band at 118kDa [α-ENaC 
(90 kDa) plus YFP (27 kDa) and FLAG (1 kDa)]. V5-tagged β-ENaC construct was detected with 
anti-V5 antibody, at 96kDa [β-ENaC (95 kDa) plus V5 (1 kDa). Anti-HA antibodies identified 
myc- and HA-tagged γ-ENaC at 97 kDa (γ-ENaC (95 kDa) plus myc (1kD) and HA (1kDa)) 
(Figure 4.1).  
Figure 4.1 Representative western blots of epitope-tagged epithelial sodium channel (ENaC) 
subunits at the cell surface of A549 cells.  A549 cells were co-transfected with α-, β- and γ-ENaC 
and biotin-streptavidin pull down assays followed by western blot analysis were performed with 
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anti-GFP, anti-V5 and anti-HA antibodies to recognize α-ENaC (118 kDa), β-ENaC (96 kDa) and 
γ-ENaC (97 kDa), respectively.  
Since simultaneous co-expression of three ENaC subunits had negative effects on cell viability, we 
decided to investigate the impact of hypercapnia on the α/β-ENaC complex. Although ENaC is a 
multimeric channel that may contain different combinations of three structurally related subunits, 
at least one α- or δ-subunit of ENaC is required to produce amiloride-sensitive current (Canessa et 
al. 1994; McNicholas and Canessa 1997; Hanukoglu and Hanukoglu 2016). β- and γ-ENaC are 
crucial for channel trafficking and interestingly, they have high amino-acids homology, thus 
probably exhibit similar function (Bhalla and Hallows 2008).  
Biotin-streptavidin pull down assays were performed to study the cell surface abundance of α- and 
β-ENaC in A549 and ATII cells upon exposure to 40 mmHg or 120 mmHg of CO2 (normocapnia; 
Ctrl and hypercapnia; CO2, respectively) at a pHe of 7.4 for 30 min. Expression of the α/β-ENaC 
complex at the plasma membrane was significantly higher in cells exposed to normocapnia 
compared to those exposed to hypercapnia. Treatment of cells with high CO2 levels decreased 
number of α- and β-ENaC molecules at the cell surface of A549 cells by approximately 60% 
(Figure 4.2). 
Figure 4.2 Representative western blots and quantification of α- and β-ENaC expression at 
the surface of A549 cells upon normocapnia and hypercapnia. A549 cells were transfected with 
α- and β-ENaC and were treated with 40 mmHg CO2 (Ctrl) or 120 mmHg CO2 (CO2) for 30 min at 
a pHe of 7.4. The plasma membrane (PM) expression of the proteins was determined by cell surface 
biotinylation and subsequent immunoblotting with anti-GFP (α-ENaC), anti-V5 (β-ENaC) and 
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anti-transferrin receptor (TfR) antibody. TfR was used as a loading control. Bars represent mean ± 
SEM. n=3, ***p<0.001.  
Having shown that hypercapnia affected cell surface stability of ENaC proteins in A549 cells, we 
next asked whether elevated CO2 levels cause similar effects in primary ATII cells. The 
transfection of these cells remains difficult however, we recently reported that nucleofection leads 
to highly efficient DNA delivery without affecting integrity of ATII cells, even when high amount 
of plasmidic DNA is delivered (Grzesik et al. 2013). Rat primary ATII cells were nucleofected 
with plasmids encoding α- and β-ENaC and were treated with normocapnia (Ctrl) or hypercapnia 
(CO2) for 30 min at a pHe of 7.4. 18 h after transfection the density of ENaC subunits at the plasma 
membrane was determined by cell surface biotinylation. Analysis of α- and β-ENaC membrane 
expression revealed that elevated CO2 levels increased ENaC endocytosis in ATII cells (Figure 
4.3). The hypercapnia-treated cells exhibited a reduction of α-ENaC cell surface expression by 
approximately 70%, compared to α-ENaC levels measured upon normocapnic exposure. The 
concentration of β-ENaC at the plasma membrane was decreased by ~50% upon exposure to 
elevated CO2. These data are similar to the results obtained using immortalized human A549 cells, 
suggesting that ENaC regulation by hypercapnia is comparable in both cell lines. 
Figure 4.3 Representative western blots and quantification of α- and β-ENaC expression at 
the surface of ATII cells upon normocapnia and hypercapnia treatment. ATII cells were co-
transfected with α- and β-ENaC and exposed to 40 mmHg CO2 (Ctrl) or 120 mmHg CO2 (CO2) for 
30 min at a pHe of 7.4. By streptavidin pull downs and western blot analysis the plasma membrane 
(PM) expression of the ENaC proteins and transferrin receptor (TfR) was determined. Bars 
represent mean ± SEM. n=3, ***p<0.001. 
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The importance of α-ENaC in AFC has been reported previously (Hummler et al. 1996). Our results 
from the biotinylation assays indicated a significant reduction of α-ENaC cell surface abundance 
upon acute hypercapnia exposure. To further confirm these effects of hypercapnia, 
immunofluorescence studies were conducted in which localization of α-ENaC was observed after 
exposure of A549 cells to normocapnic (Ctrl) or hypercapnic (CO2) solutions at a pHe of 7.4 for 
30 min. In cells treated with hypercapnia, immunofluorescence images showed a predominantly 
intracellular localization of α-ENaC and a marked decrease of channel abundance at the cell surface 
when compared to normocapnic controls, suggesting that hypercapnia induces translocation of 
ENaC form the cell surface to intracellular compartments (Figure 4.4).  
Figure 4.4 Fluorescent images of subcellular localization of α-ENaC in A549 cells upon 
normocapnic and hypercapnic exposure.  A549 cells were treated with 40 mmHg CO2 (Ctrl) or 
120 mmHg CO2 (CO2) for 30 min at a pHe of 7.4 and cellular distribution of α-ENaC was assessed 
by using an anti α-ENaC antibody followed by Alexa Fluor 488-conjugated secondary antibody. 
Nuclei were labeled with DAPI. Scale bar =10 μm. 
4.2 Short-term hypercapnia does not modify total intracellular level of ENaC in alveolar 
epithelial cells 
Next, we evaluated the impact of elevated CO2 concentrations on total intracellular levels of ENaC 
in A549 and ATII cells. Both cell types were transfected with α- and β-ENaC prior to exposure to 
normocapnia (Ctrl) or hypercapnia (CO2) for 30 min at a pHe of 7.4 and total amounts of α- and β-
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ENaC proteins were determined in whole cell lysates. Importantly, intracellular concentrations of 
the channel subunits remained unchanged in A549 (Figure 4.5A) and in ATII cells (Figure 4.5B) 
further confirming that elevated CO2 levels probably induced trafficking of ENaC from the plasma 
membrane.  
Figure 4.5 Representative immunoblots and quantifications of intracellular expression levels 
of ENaC in human and rat alveolar epithelial cells upon normocapnia and hypercapnia 
treatment. (A) A549 cells were co-transfected with α- and β-ENaC and were exposed to 40 mmHg 
CO2 (Ctrl) or 120 mmHg CO2 (CO2) for 30 min at a pHe of 7.4. The whole cell levels (WCL) of 
ENaC proteins were determined by western blot analysis with anti-GFP (α-ENaC) and anti-V5 (β-
ENaC) antibodies. (B) ATII cells were co-transfected and exposed to normo- or hypercapnia as 
described above and the total levels of ENaC proteins were assessed by western blot analysis with 
the above mentioned antibodies. β-actin was used as a loading control. Bars represent mean ± SEM. 
n=3-4.  
4.3 Impact of acute hypercapnia on ENaC mRNA expression 
In next phase of our studies, the potential effects of hypercapnia on mRNA expression of ENaC 
subunits were investigated. To this end, A549 cells were treated with either normocapnia (Ctrl) or 
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hypercapnia (CO2) for 30 min at a pHe of 7.4. After treatment, isolated mRNA was converted to a 
complementary DNA (cDNA) and real-time PCR was performed. Of note, the levels of transcripts 
encoding α- and β-ENaC were not changed upon acute hypercapnia treatment (Figure 4.6). These 
results are in agreement with previous findings showing that short-term exposure of ENaC to 
various pathological stimuli (hypoxia or TGF-β) at least initially do not change the transcriptional 
expression of the channel (Gille et al. 2014; Peters et al. 2014). 
Figure 4.6 Relative mRNA levels of α- and β-ENaC upon acute hypercapnia treatment. A549 
cells were exposed to 40 mmHg CO2 (Ctrl) or 120 mmHg CO2 (CO2) for 30 min at a pHe of 7.4 
prior to RNA isolation (n=3). The mRNA levels of ENaC subunits were analyzed by real-time PCR 
and normalized to GAPDH.  
4.4 Hypercapnia increases ENaC endocytosis by promoting β-ENaC polyubiquitination  
Cell surface expression of ENaC is regulated by ubiquitin-dependent endocytosis (Knight et al. 
2006; Eaton et al. 2010; Rotin and Staub 2012), thus the aim of the next studies was to assess the 
role of ubiquitination in the hypercapnia-mediated increase in ENaC retrieval from the cell surface. 
To this end, each ENaC subunit was overexpressed with human epitope-tagged ubiquitin: either 
HA-tagged (HA-Ub) (in case of α- and β-ENaC overexpression) or His-tagged (His-Ub) (when 
cells were transfected with γ-ENaC). After transfection A549 cells were treated with normocapnia 
(Ctrl) or hypercapnia (CO2) for 15 min and immunoblotting was performed. Hypercapnia 
significantly increased ubiquitination of β-ENaC (but not α or γ) in total cell lysate of A549 cells 
as was detected by overexposing films after treating the membranes with the various antibodies 
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against the tags of the ENaC constructs, which allows identification of ubiquitinated proteins. The 
results showed that a very short exposure to hypercapnia (15 min) promotes β-ENaC 
polyubiquitination detected as a “characteristic smear” above the predicted size of β-ENaC 
(96kDa) (Figure 4.7B). In contrast, short-term hypercapnia did not promote ubiquitination of α- or 
γ-ENaC (Figure 4.7A and C, respectively).  
Figure 4.7 Representative immunoblots of α-, β-and γ-ENaC ubiquitination in A549 cells 
upon normocapnic and hypercapnic exposure. A549 cells were transfected with (A) α-ENaC 
and HA-ubiquitin, (B) β-ENaC and HA-ubiquitin or (C) γ-ENaC and His-ubiquitin prior to 
exposure to 40 mmHg CO2 (Ctrl) or 120 mmHg CO2 (CO2) for 15 min at a pHe of 7.4. Total 
ubiquitinated α-, β- and γ-ENaC were detected by immunoblotting with anti-GFP, anti-V5 and anti-
HA antibodies, respectively. β-actin was used as loading control. 
An increase in β-ENaC polyubiquitination upon elevated CO2 concentrations was confirmed by 
the next set of experiments, in which ubiquitinated ENaC isoforms were detected by co-
immunoprecipitation. In these studies, A549 cells were co-transfected with β-ENaC and HA-
ubiquitin prior to treatment with normocapnia (Ctrl) or hypercapnia (CO2) for 30 min. β-ENaC was 
immunoprecipitated with rabbit anti-V5 antibody and its ubiquitinated conjugates were identified 
using a mouse anti-HA antibody. The exposure of cells to hypercapnia resulted in a typical 
polyubiquitination smear, similar to that observed when using overexposure of films (Figure 4.8).  
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Figure 4.8 A representative immunoprecipitation experiment presenting β-ENaC 
polyubiquitination in A549 cells upon normal and elevated CO2 exposure. A549 cells were co-
transfected with β-ENaC-V5 and human HA-tagged ubiquitin prior to exposure to 40 mmHg CO2 
(Ctrl) or 120 mmHg CO2 (CO2) for 30 min at a pHe of 7.4. β-ENaC was immunoprecipitated with 
anti-V5 antibody and its ubiquitinated conjugates were visualized by using a mouse anti-HA-
antibody.  
4.5 Hypercapnia inhibits epithelial Na+ transport 
Several Na+ channels and Na+-coupled transporters have been found to be expressed in alveolar 
epithelial cells so far, of which ENaC has been associated with the most important role in AFC 
(Canessa et al. 1994; Voilley et al. 1994; Matalon and Brodovich 1999; Fronius et al. 2012). Thus, 
we hypothesized that the hypercapnia-induced reduction in ENaC cell surface expression may 
contribute to reduced alveolar fluid transport capacity and persistence of pulmonary edema. 
To this end, the effects of acute hypercapnia on Na+ transport across polarized monolayers of H441 
cells were evaluated by electrophysiological studies. The confluent cell monolayers were treated 
with normocapnia (Ctrl) or hypercapnia (CO2) for 30 min. at a pHe of 7.4 prior to mounting to an 
Ussing chamber. The transepithelial potential (Vt) was continuously recorded and short circuit 
current (Isc) was calculated. The bioelectrical properties of H441 cells under normocapnic and 
hypercapnic conditions were compared and revealed impairments of total (Isc) as well as amiloride-
sensitive (Iamil-sens) currents, suggesting downregulation of ENaC activity secondary to the 
reduction of ENaC cell surface expression in response to elevated CO2 levels. In normocapnia-
treated cells, a mean Isc of 9.5 µA/cm2 was detected across H441 monolayers. This current was 
inhibited by approximately 50% after addition of 10 µM amiloride. Treatment of cells with high 
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CO2 levels decreased Isc to 7.0 µA/cm2, which corresponds to a 25% decrease compared to Isc of 
normocapnia-treated cells (Figure 4.9A). Elevated CO2 levels primarily affected the amiloride-
sensitive fraction of the current, which decreased from 6.2 µA/cm2 in control cells to 3.8 µA/cm2 
after hypercapnia treatment, representing a 40% decrease in Iamil-sens (Figure 4.9B). In contrast, the 
amiloride-insensitive current (Iamil-insens) remained unchanged (Figure 4.9C). Similarly, there was 
no significant difference in Rt between the short-term normocapnic and hypercapnic conditions 
(Figure 4.9D).  
Figure 4.9 Hypercapnia decreases basal and amiloride-sensitive current of H441 cells. (A-D) 
Data from three independent experiments showing comparision between (A) total current; Isc, (B) 
amiloride-sensitive current; Iamil-sens (C) amiloride-insensitive current; Iamil-insens and  (D) 
transepithelial resistance; RT  of H441 monolayers treated with 40 mmHg CO2 (Ctrl) or 120 mmHg 
CO2 (CO2) for 30 min at a pHe of 7.4. Amiloride (10µM) was added at the end of the experiments 
to the apical compartment. Bars shows mean ± SEM (n = 3; * p < 0.05). 
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4.6 Nedd4-2 drives elevated CO2-induced ENaC polyubiquitination and retrieval from the 
cell surface 
Various studies have identified Nedd4-2 as a key regulator of ENaC stability in the cytoplasm and 
cellular membrane (Abriel et al. 1999; Snyder et al. 2001; Knight et al. 2006; Boase et al. 2011; 
Rotin and Staub 2011). To determine the possible contribution of Nedd4-2 to β-ENaC 
polyubiquitination in the hypercapnic signaling pathway we first, co-transfected A549 cells with 
β-ENaC-V5 and HA-Nedd4-2 and exposed to normocapnia (Ctrl) or hypercapnia (CO2) for 30 min. 
β-ENaC was immunoprecipitated with anti-V5 antibody and the presence of Nedd4-2 in 
immunoprecipitated complex was confirmed by immunoblotting with anti-HA antibody. We found 
that Nedd4-2 was associated with β-ENaC in A549 cells when exposed to either regular or elevated 
CO2 levels, suggesting that Nedd4-2 binds to β-ENaC during normal protein turnover, but also in 
stress conditions such as upon hypercapnia (Figure 4.10).  
Figure 4.10 A representative co-immunoprecipitation experiment presenting binding of β-
ENaC to Nedd4-2 upon normocapnic and hypercapnic exposure. A549 cells were co-
transfected with β-ENaC-V5 and HA-Nedd4-2 prior to treatment with 40 mmHg CO2 (Ctrl) or 120 
mmHg CO2 (CO2) for 30 min at a pHe of 7.4. β-ENaC was immunoprecipitated from the total lysate 
with an anti-V5 antibody and Nedd4-2 was detected with an anti-HA antibody. IgG and input were 
used as negative and possitive controls, respectively.  
Next, endogenous levels of Nedd4-2 were silenced by a specific siRNA. A549 cells were treated 
with siRNA against Nedd4-2 or scrambled (si-Scr) siRNA 24 h prior to nucleofection with β-ENaC 
and HA-ubiquitin. Next, cells were exposed to normocapnia (Ctrl) or hypercapnia (CO2) for 30 
min at a pHe of 7.4 and the levels of β-ENaC ubiquitination were detected with overexposure of 
films after treating the membranes with an anti-V5 antibody. Indeed, our data demonstrated that 
knock-down of Nedd4-2 significantly prevented the CO2-induced polyubiquitination of β-ENaC 
(Figure 4.11). 
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Figure 4.11 Nedd4-2 mediates hypercapnic polyubiquitination of β-ENaC.  A549 cells were 
co-transfected with β-ENaC, HA-ubiquitin, and siRNA targeting Nedd4-2 or a scrambled (si-Scr.) 
siRNA prior to exposure to 40 mmHg CO2 (Ctrl) or 120 mmHg CO2 (CO2) for 30 min at a pHe of 
7.4. β-ENaC polyubiquitinated isoforms were determined by western blot with anti-V5 antibody.  
To next test whether Nedd4-2 silencing changed ENaC plasma membrane expression upon 
hypercapnia treatment, biotin-streptavidin pull down assays were performed. A549 cells were 
treated with siRNA targeting Nedd4-2 or a scrambled siRNA 24 h before transfection with ENaC 
plasmids. Then cells were exposed to normocapnia (Ctrl) or hypercapnia (CO2) for 30 min. In line 
with our previous findings, suggesting the involvement of Nedd4-2 in the hypercapnia-induced 
ubiquitination of β-ENaC, A549 cells transfected with siRNA against Nedd4-2 showed a 
significant increase of α- and β-ENaC concentrations at the cell surface compared to cells 
transfected with a scrambled siRNA and treated with elevated CO2 levels (Figure 4.12).  
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Figure 4.12 Silencing of Nedd4-2 prevents hypercapnia-induced endocytosis of the α/β-ENaC 
complex. A549 cells were co-transfected with α-, β-ENaC and a siRNA against Nedd4-2 or a 
scrambled (si-Scr.) siRNA prior to exposure to 40 mmHg CO2 (Ctrl) or 120 mmHg CO2 (CO2) for 
30 min at a pHe of 7.4. The plasma membrane (PM) expression of ENaC subunits and transferrin 
receptor (TfR) was determined by streptavidin pull-down followed by western blot analysis. 
Representative western blots of ENaC proteins and Nedd4-2 are presented. Bars show mean ± SEM 
(n = 3; ** p < 0.01) 
4.7 Hyperapnia-induced internalization of α/β-ENaC complex is mediated by ERK1/2-
dependent phosphorylation of β-ENaC 
Since silencing of Nedd4-2 prevented the hypercapnia-induced β-ENaC polyubiquitination, we 
speculated that the interaction of these two proteins may be promoted by hypercapnia. Since 
hypercapnia significantly increased Nedd4-2-dependent polyubiquitination of β-ENaC, we 
hypothesized that a kinase or kinases activated by hypercapnia may directly or indirectly enhance 
interaction of β-ENaC and Nedd4-2, as it is well documented that several target proteins undergo 
phosphorylation prior to ubiquitination (Nguyen et al. 2013) 
First, we tested activation of ERK1/2 in A549 cells upon hypercapnia exposure. For this, cells were 
exposed to normal (Ctrl) or elevated (CO2) CO2 levels for up to 45 min at a pH of 7.4. In line with 
a previous report (Welch et al. 2010), our results showed a rapid and time-dependent ERK1/2 
phosphorylation (that correlates with the activity of the kinase) (Blenis 1993; Cobb and Goldsmith 
1995) induced by CO2 that returned to basal level after 45 min of hypercapnia treatment (Figure 
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4.13A). Since a marked increase of ERK1/2 activity during hypercapnia was detected, next the 
effect of ERK1/2 activation on β-ENaC phosphorylation status was assessed. A549 cells were 
transfected with β-ENaC and exposed to normal (Ctrl) or elevated (CO2) CO2 levels for 5 to 15 
min. Immunoblots were performed with anti-phospho SCNN1B antibody (specifically recognizes 
β-ENaC when phosphorylated at the T615). In agreement with previous reports (Shi et al. 2002; 
Yang et al. 2006; Lazrak et al. 2012; Eaton et al. 2014), we detected a time-dependent increase of 
β-ENaC phosphorylation at the T615 residue in the presence of active ERK1/2 (Figure 4.13B). 
Figure 4.13 Representative western blots and quantification of time-dependent activation of 
ERK1/2 and phosphorylation of β-ENaC at T615 residue upon normocapnia and 
hypercapnia treatment. (A) A549 cells were treated with 40 mmHg CO2 (Ctrl) for 15 min or 120 
mmHg CO2 (CO2) for 5 to 45 min at a pHe of 7.4. Phosphorylated and total levels of ERK1/2 were 
measured by western blot analysis. The graph shows phospho/total ERK1/2 ratio. (B) A549 cells 
were transfected with β-ENaC prior to exposure to normocapnia (Ctrl) for 15 min or hypercapnia 
(CO2) for 5-15 min. Phoporylation of β-ENaC at the T615 residue and total level of β-ENaC were 
determined by immunoblotting with anti-phospho SCNN1B antibody and with anti-V5 antibody, 
respectively. The graph presents phospho/total β-ENaC ratio. Representative western blots are 
shown. Bars show mean ± SEM (n = 3; * p < 0.05; ** p < 0.01; *** p < 0.001). 
To further investigate whether activation of ERK1/2 was necessary for the hypercapnia-induced 
ubiquitination of ENaC, A549 cells were transfected with β-ENaC and HA-ubiquitin. 18 h later the 
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transfected cells were pretreated with 10 µM U0126 (MEK inhibitor, upstream of ERK1/2) for 30 
min before exposure to normal (Ctrl) or elevated (CO2) CO2 levels for additional 30 min. The 
polyubiquitination of β-ENaC was determined by immunoblotting with an anti-V5 antibody. 
Importantly, ERK1/2 inhibition prevented the hypercapnia-induced phosphorylation and 
polyubiquitination of the β-subunit of ENaC (Figure 4.14).   
Figure 4.14 Inhibition of ERK1/2 prevents hypercapnia-induced polyubiquitination of β-
ENaC in A549 cells. A549 cells were co-tranfected with β-ENaC and HA-ubiquitin before 
treatment with 40 mmHg CO2 (Ctrl) or 120 mmHg CO2 (CO2) for 30 min at a pHe of 7.4 in the 
presence or absence of 10 µM U0126 (30 min pretreatment). Ubiquitinated β-ENaC was detected 
with anti-V5 antibody. Representative western blots are shown. 
The above described studies confirmed that ERK1/2 via β-ENaC phophorylation affects ENaC 
ubiquitnation upon hypercapnia exposure. To futher study if the hypercapnia-induced ENaC 
endocytosis is also dependent on ERK1/2, we measured cell surface abundance of ENaC subunits 
by biotinylation assays after A549 cells were exposed to normocapnia or hypercapnia for 30 min 
at a pHe of 7.4 in the presence or absence of 10 µM U0126 (30 min pretreatment). Indeed, 
pretreatment of A549 cells with U0126 prevented the hypercapnia-induced decrease in cell surface 
ENaC abundance (Figure 4.15). Thus, hypercapnia-induced activation of ERK1/2 leads to direct 
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phosphorylation of β-ENaC, which drives polyubiquitination and subsequent endocytosis of ENaC 
from the alveolar epithelial cell surface.  
Figure 4.15 Inhibition of ERK1/2-mediated β-ENaC phosphorylation prevents retrieval of 
the α/β-ENaC complex from the cell surface. A549 cells were co-transfected with α- and β-ENaC 
and were exposed to 40 mmHg CO2 (Ctrl) or 120 mmHg CO2 (CO2) for 30 min at a pHe of 7.4 in 
the presence or absence of U0126 (10 µM, 30 min pretreatment). The plasma membrane (PM) 
abundance of ENaC proteins and transferrin receptor (TfR) was measured by biotinylation assay 
followed by western blot analysis. Representative western blots of ENaC proteins located at the 
cell surface and total cellular protein levels, as well as phophorylation levels of ERK1/2 are shown. 
Bars show mean ± SEM (n = 3; ** p < 0.01). 
As we demonstrated a central role for β-ENaC phosphorylation at T615 in the trafficking of the 
channel during hypercapnia, in subsequent experiments we removed T615 from the amino-acids 
sequence of β-ENaC by the Gibson assembly technique to investigate whether prevention of β-
ENaC phosphorylation at this residue may attenuate the hypercapnia-induced decrease of ENaC 
cell surface abundance. Therefore, A549 cells were transfected with α-ENaC and either wild type 
(β-WT) or mutant (β-ΔT615) β-ENaC and were then exposed to normocapnia (Ctrl) or hypercapnia 
(CO2) for 30 min. Cell surface expression of the ENaC subunits was assessed by biotin-streptavidin 
pull down. In line with our previous studies, preventing the ERK-dependent β-ENaC 
phosphorylation at the T615 residue rescued the cell surface abundance of the α/β-ENaC complex 
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upon hypercapnia (Figure 4.16). Thus, our results demonstrate that hypercapnia negatively controls 
the trafficking of α/β-ENaC by initiation of a specific CO2-induced signaling pathway that includes 
activation of ERK1/2 and phophorylation of β-ENaC.  
Figure 4.16 Deletion of the T615 residue of β-ENaC prevents the hypercapnia-induced ENaC 
endocytosis.  A549 cells were co-transfected with α-ENaC and either wild type (WT) or mutated 
(ΔT615) β-ENaC prior to exposure to 40 mmHg CO2 (Ctrl) or 120 mmHg CO2 (CO2) for 30 min 
at a pHe of 7.4. The plasma membrane (PM) density of ENaC proteins was measured by biotin-
streptavidin pull down assay. Representative western blots are shown. Bars show mean ± SEM (n 
= 4; *** p < 0.001; ** p < 0.01). 
4.8 Hypercapnia affects ubiquitination and cell surface expression of ENaC by JNK-
dependent Nedd4-2 phosphorylation  
Since JNK1/2 is also implicated in the CO2–induced signaling cascade in alveolar epithelial cells 
leading to inhibition of the Na,K-ATPase, as reported previously by our laboratory (Vadász et al. 
2012), we next investigated the role of JNK in ENaC trafficking during CO2 exposure. First, we 
studied the activation of JNK1/2 in A549 cells treated with hypercapnia by measuring the 
phosphorylation levels of c-Jun (a downstream target of JNK and thus indicator of JNK activity 
(Cargnello and Roux 2011). Consistent with our previous observations, JNK1/2 activation by 
hypercapnia was rapid and transient (Figure 4.17). 
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Figure 4.17 Representative western blots and quantification of time dependent activation of 
JNK 1/2 by hypercapnia.  A549 cells were treated with 40 mmHg CO2 (Ctrl) for 5 min or 120 
mmHg CO2 (CO2) for 1 to 30 min at a pHe of 7.4. Activation of JNK was determined by measuring 
phosphorylation of c-Jun, a downstream target of JNK1/2. The graph shows phospho-c-Jun/total 
JNK1/2 ratio. Western blots of phopho-c-Jun and the total level of JNK1/2 are shown. Bars show 
mean ± SEM (n = 3; * p < 0.05; ** p < 0.01)  
It has been previously demonstrated that JNK1 phosphorylates Nedd4-2 at the T899 residue 
thereby increasing activity of the E3 ligase. In polarized kidney epithelial cells (HEK 293), 
overexpression of a Nedd4-2 mutant lacking T899 was sufficient to attenuate α-ENaC 
ubiquitination compared to overexpression of wild type Nedd4-2 (Hallows et al. 2010). Moreover, 
overexpression of a constitutively active variant of JNK1 decreased ENaC-mediated sodium 
current in these cells. To evaluate the potential role of activated JNK in ENaC endocytosis during 
hypercapnia, we performed a site directed mutagenesis assay, in which the T899 residue of Nedd4-
2 was replaced by alanine (T899A). First, we tested the impact of the mutated Nedd4-2 on β-ENaC 
polyubiquitination. To this end, A549 cells were transfected with β-ENaC, HA-ubiquitin and either 
wild type (WT) or mutant (T899A) Nedd4-2 prior to exposure to normocapnia (Ctrl) or 
hypercapnia (CO2) for 30 min. Indeed, the level of hypercapnia-induced β-ENaC 
polyubiquitination in A549 cells expressing mutated Nedd4-2 in which the threonine residue 
cannot be phosphorylated by JNK was significantly reduced (Figure 4.18), suggesting that 
phosphorylation of Nedd4-2 at the T899 residue may impact ENaC trafficking during hypercapnia.  
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Figure 4.18 JNK-dependent Nedd4-2 phosphorylation drives hypercapnia-induced β-ENaC 
polyubiquitination.  A549 cells were co-tranfected with β-ENaC, HA-ubiquitin and either wild 
type (WT) or mutant (T899A) Nedd4-2 prior to treatment with 40 mmHg CO2 (Ctrl) or 120 mmHg 
CO2 (CO2) for 30 min at pHe of 7.4. Ubiquitinated β-ENaC was detected with anti-V5 antibody.  
Next, we tested if a decrease in β-ENaC polyubiquitination due to the lack of phophorylation at 
T899 residue of Nedd4-2 prevents the hypercapnia-induced ENaC endocytosis. A549 cells were 
co-transfected with α/β-ENaC and either WT or T899A mutant Nedd4-2. Next, cells were treated 
with normocapnia (Ctrl) or hypercapnia (CO2) for 30 min and ENaC cell surface density was 
estimated by streptavidin pull down and immunoblotting. Notably, overexpression of the Nedd4-2 
mutant fully prevented the high CO2-induced endocytosis of ENaC (Figure 4.19).  
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Figure 4.19 Overexpression of the Nedd4-2 mutant (T899A) prevents endocytosis of the α/β-
ENaC complex upon hypercapnia exposure.  A549 cells were co-transfected with α-, β-ENaC 
and either wild type (NeddWT) or mutant (NeddT889A) Nedd4-2 before treatment with 40 mmHg 
CO2 (Ctrl) or 120 mmHg CO2 (CO2) for 30 min at a pHe of 7.4. Plasma membrane (PM) expression 
of ENaC proteins was measured by biotin-streptavidin pull down assay. Western blots of α-, β-
ENaC and transferrin receptor (TfR) at the cell surface and total protein abundance of ENaCs, β-
actin, and Nedd4-2 are shown. Bars show mean ± SEM (n = 4; * p < 0.05; ** p < 0.01). 
Finally, the role of JNK in the hypercapnia-induced endocytosis of ENaC was determined. A549 
cells were pretreated with the specific JNK inhibitor, SP600125 and were then exposed to normal 
(Ctrl) or elevated (CO2) CO2 levels for 30 min. In line with the above described findings, 
pretreatment of cells with SP600125 prevented the hypercapnia-induced internalization of ENaC 
(Figure 4.20). These results suggest that two distinct members of the MAPK superfamily, ERK1/2 
and JNK1/2, are implicated in downregulation of ENaC upon exposure of alveolar epithelial cells 
to elevated CO2 levels, targeting different proteins, namely β-ENaC and Nedd4-2, respectively. 
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Figure 4.20 JNK1/2 inhibition prevents elevated CO2-induced endocytosis of the α/β-ENaC 
complex. A549 cells were co-transfected with α- and β-ENaC and exposed to 40 mmHg CO2 (Ctrl) 
or 120 mmHg CO2 (CO2) in the presence or absence of SP600125 (25 µM, 30 min pretreatment) 
for 30 min at a pHe of 7.4. The plasma membrane (PM) density of ENaC subunits was assessed by 
biotinylation and immunoblotting. Representative western blots are shown. Bars show mean ± 
SEM (n = 4; ** p < 0.01; *** p < 0.001). 
4.9 Elevated CO2 levels promote endocytosis of the α/β-ENaC complex by AMPK-α1 
activation 
Recently, the regulatory role of AMPK in ENaC/Nedd4-2 interaction has been reported 
(Woollhead et al. 2005; Bhalla et al. 2006; Almaça et al. 2009). Moreover, our group has previously 
identified AMPK-α1 as another important signaling molecule involved in the dysregulation of 
Na,K-ATPase during hypercapnia exposure (Vadász et al. 2008). Based on these findings, we 
hypothesized that the AMPK/Nedd4-2 axis may also regulate functional expression of ENaC in the 
alveolar epithelium during hypercapnia. To test this hypothesis, first we measured the levels of 
phospho-AMPK-α1 in A549 cells exposed to elevated CO2 concentrations. Confirming our 
previous observations, hypercapnia induced the phosphorylation of AMPK-α1 in a time-dependent 
manner. AMPK-α1 activation was fast, transient and returned to baseline within 45 min of exposure 
to hypercapnia (Figure 4.21A). Moreover, the activity of AMPK-α1 was measured in A549 cells 
treated with normocapnia (Ctrl) or hypercapnia (CO2) in the presence of the ERK inhibitor, U0126 
(10 µM, 30 min pretreatment) for 30 min. The results demonstrated that phosphorylation of AMPK 
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was strongly dependent on the activity of ERK1/2 (Figure 4.21B), confirming that AMPK is a 
downstream target of ERK1/2 in the hypercapnic signaling pathway (Welch et al. 2010).  
Figure 4.21 Hypercapnia induces ERK1/2-dependent activation of AMPK-α1.  (A) A549 cells 
were treated with 40 mmHg CO2 (Ctrl) for 15 min or 120 mmHg CO2 (CO2) for 15 to 45 min at a 
pHe of 7.4. The levels of phosphorylated and total AMPK-α1 were measured by immunoblotting. 
Graph shows phospho/total AMPK-α1 ratio. (B) A549 cells were exposed to normo- vs 
hypercapnia for 15 min at a pH of 7.4 in the presence of DMSO (vehicle) or U0126 (10 µM, 30 
min pretreatment) and phosphorylation levels of AMPK-α1 and ERK1/2 were determined by 
immunoblotting. Graph shows phospho/total AMPK-α1 ratio. Representative blots are shown. Bars 
show mean ± SEM (n = 3; *p < 0.05; *** p < 0.001). 
Next, we aimed to determine whether activation of AMPK-α1 is required for downregulation of 
ENaC upon hypercapnia. To this end, we first tested the levels of β-ENaC polyubiquitination in 
A549 cells exposed to normocapnia (Ctrl) or hypercapnia (CO2) for 30 min after pharmacological 
inhibition or silencing of AMPK-α1, using a specific AMPK inhibitor, compound C or a siRNA 
respectively. In A549 cells pretreated with compound C prior to hypercapnia treatment, 
polyubiquitination of β-ENaC was significantly reduced (Figure 4.22A). The effects of elevated 
CO2 levels on β-ENaC polyubiquitination were also abolished after AMPK-α1 silencing (Figure 
4.22B). These results suggest that the hypercapnia-induced AMPK-α1 activation is required to 
promote polyubiquitination of β-ENaC. 
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Figure 4.22 Active AMPK-α1 mediates β-ENaC polyubiquitination upon hypercapnia.  (A) 
A549 cells were co-tranfected with β-ENaC and HA-ubiquitin and were treated with 40 mmHg 
CO2 (Ctrl) or 120 mmHg CO2 (CO2) for 30 min at a pHe of 7.4 in the presence or absence of 
compound C (Comp. C; 20 µM, 30 min pretreatment). Ubiquitinated β-ENaC was detected with 
anti-V5 antibody. (B) A549 cells were transfected with either a siRNA against AMPK-α1 (si-
AMPK-α1) or a scrambled siRNA (si-Scr.) and with β-ENaC and HA-ubiquitin prior to treatment 
with normocapnia or hypercapnia and ubiquitinated isoforms of β-ENaC were detected as 
described above. Representative western blots of β-ENaC, phopho-AMPK-α1 and total AMPK-α1 
are shown.  
We next tested whether activation of AMPK was also necessary for the hypercapnia-induced 
retrieval of the α/β-ENaC complex from the cell surface. To assess that, A549 cells were transfected 
with α- and β-ENaC and treated with DMSO or compound C prior to normocapnia or hypercapnia 
exposure for 30 min and expression of the ENaC subunits at the plasma membrane was determined. 
Our results showed that AMPK-α1 inhibition stabilized the ENaC complex at the cell surface 
during hypercapnia (Figure 4.23).  
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Figure 4.23 Inhibition of AMPK-α1 prevents elevated CO2-induced α/β-ENaC complex 
endocytosis.  A549 cells were co-transfected with α- and β-ENaC and exposed to 40 mmHg CO2 
(Ctrl) or 120 mmHg CO2 (CO2) for 30 min at a pHe of 7.4 in the presence or absence of compound 
C (20 µM, 30 min pretreatment). The plasma membrane (PM) expression of the α/β-ENaC complex 
was evaluated by streptavidin pull down followed by western blot analysis. Bars show mean ± 
SEM (n = 4; * p < 0.05; ** p < 0.01). 
Paralleling the results obtained with pharmacological inhibition of AMPK, a specific siRNA 
targeting AMPK-α1 also prevented the hypercapnia-induced ENaC endocytosis (Figure 4.24).  
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Figure 4.24 Silencing of AMPK increases cell surface stability of ENaC upon hypercapnia 
exposure. A549 cells were co-transfected with α-, β-ENaC and siRNA targeting either AMPK-α 
or scrambled (si-Scr). Next cells were treated with 40 mmHg CO2 (Ctrl) or 120 mmHg CO2 (CO2) 
for 30 min at a pHe of 7.4. The plasma membrane (PM) expression of ENaC proteins was measured 
by biotinylation and western blots. Representative immunoblots of ENaC proteins and AMPK-α 
silencing  are shown. Bars shows mean ± SEM (n = 4; * p < 0.05; ** p < 0.01). 
These studies established that AMPK-α1 is strongly activated during hypercapnia and is 
downstream of ERK1/2. Several reports have shown that phosphorylation status of AMPK is 
regulated by other kinases including CaMKK-β (Woods et al. 2005; Gusarova et al. 2011). To 
further explore the role of CaMKK-β in the hypercapnia-induced and AMPK-mediated ENaC 
downregulation, A549 cells were exposed to normal or elevated CO2 levels in the presence or 
absence of the CaMKK-β inhibitor, STO609 (20 μg/ml, 30 min preincubation) and activation of 
AMPK-α1 was assessed. Our results showed that during hypercapnia the phosphorylation of 
AMPK-α1 was driven by CaMKK-β (Figure 4.25A). Next, the biotinylation assay was applied to 
measure the level of ENaC proteins at the cell surface of A549 cells exposed to normocapnia or 
hypercapnia in the presence of STO609. Similar to the results obtained with U0126 (MEK 
inhibitor), the plasma membrane abundance of the α/β-ENaC complex was restored to normal 
levels when phosphorylation of AMPK-α1 was prevented upon exposure to elevated CO2 
concentrations (Figure 4.25B).  
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Figure 4.25 Inhibition of CaMKK-β prevents elevated CO2-induced endocytosis of the α/β-
ENaC complex. (A) A549 cells were treated with 40 mmHg CO2 (Ctrl) or 120 mmHg CO2 (CO2) 
for 15 min at a pHe of 7.4 in the presnece or absence of STO609 (20 μg/ml, 30 min preincubation). 
Phosphorylated and total levels of AMPK-α1 were determined by western blot analysis. (B) A549 
cells were co-transfected with α- and β-ENaC and exposed to normocapnia or hypercapnia for 30 
min in the presence or absence of STO609. The plasma membrane (PM) expression of ENaC 
proteins was assessed by biotin-streptavidin pull down followed by immunoblotting. 
Representative western blots are shown. Bars show mean ± SEM (n = 4; * p < 0.05; ** p < 0.01). 
Additionally, we observed that pharmacological inhibition of AMPK-α1, via compound C, strongly 
prevented the phosphorylation of c-Jun (Figure 4.26). This observation are in line with the previous 
finding describing that CO2-induced activation of JNK requires activation of AMPK (Vadász et al. 
2012). Collectively, these latter results suggest that AMPK-dependent JNK activation mediates 
Nedd4-2 phosphorylation at T899, thereby promoting polyubiquitination of ENaC-β and 
internalization of the α/β-ENaC complex. 
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Figure 4.26 Activation of AMPK-α1 is required to promote JNK phosphorylation during 
exposure to elevated CO2 levels. A549 cells were treated with 40 mmHg CO2 (Ctrl) or 120 mmHg 
CO2 (CO2) for 5 min at a pHe of 7.4 in the presence or absence of compound C (20 µM, 30 minutes). 
Phosphorylation levels of c-Jun, AMPK-α1 and total amounts of JNK1/2 and AMPK-α1 were 
measured by western blot analysis. The graph shows phospho c-Jun/total JNK1/2 ratio. 
Representative western blots of phophorylated c-Jun and are shown. Bars show mean ± SEM (n = 
3; * p < 0.05). 
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5. Discussion 
Optimal alveolar fluid balance is maintained through the activity of ENaC and CFTR expressed at 
the apical surface of epithelial cell and via the basolateral Na,K-ATPase (Matthay et al. 2002). 
Dysregulation of these transporters may result in lung flooding, as observed in ARDS, which 
disturbs gas exchange leading to hypoxia and hypercapnia (Ware and Matthay 2001; Vadász and 
Sznajder 2017) or in lung dehydration, as in cystic fibrosis (Bangel et al. 2008). While in majority 
of patients with ARDS hypoxia can be corrected by mechanical ventilation with O2 
supplementation, the lung protective ventilation strategies with low tidal volumes that are required 
to prevent further ventilator-induced lung damage often leads to further CO2 retention (Vadász et 
al. 2012; Bellani et al. 2016).  
Although the CO2 sensor remains unidentified, recent studies have shown that hypercapnia is 
sensed by lung cells and impairs alveolar epithelial function by Na,K-ATPase downregulation 
(Briva et al. 2007; Chen et al. 2008; Vadász et al. 2008; Dada et al. 2015). Most recently, the effects 
of high CO2 levels on CFTR and the hemichannel, connexin 26 have been described (Turner 2014; 
de Wolf et al. 2017) however, the potential impact of hypercapnia on ENaC has not been previously 
investigated. 
In this study, we investigated the molecular mechanism by which acute hypercapnia (dys)regulates 
functional expression of ENaC. We performed a series of experiments, which demonstrate that 
short-term hypercapnia reduces ENaC cell surface expression thus inhibiting ENaC-driven 
transepithelial Na+ transport. We established that elevated CO2 levels initiate activation of ERK1/2 
that directly phosphorylates β-ENaC at the T615 residue. Furthermore, ERK1/2- and CaMKK-β-
driven activation of AMPK-α1 stimulates JNK1/2-mediated Nedd4-2 phosphorylation at the T899 
residue. These phosphorylation events promote interaction of β-ENaC and the E3 ligase, Nedd4-2 
leading to enhanced polyubiquitination of β-ENaC and thus increased endocytosis of the α/β-ENaC 
complex from the cell surface of alveolar epithelial cells.  
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Figure 5.1 Schematic representations of the signaling pathways impairing cell surface 
expression of the epithelial Na+ channel (ENaC) upon acute hypercapnia. In alveolar epithelial 
cells (AEC), hypercapnia increases intracellular Ca2+ concentrations leading to activation of 
Ca2+/calmodulin-dependent kinase kinase (CaMKK-β), which phosphorylates and activates AMP-
activated protein kinase (AMPK). Activated AMPK promotes c-Jun N-terminal kinase (JNK)-
mediated phosphorylation of the E3 ligase Nedd4-2, which promotes ENaC β-subunit 
polyubiquitination, leading to endocytosis of the α/β-ENaC complex. In parallel, hypercapnia 
stimulates activation of ERK1/2 (upstream of AMPK), which directly phosphorylates β-ENaC thus 
facilitating the interaction with Nedd4-2 and further promotes ENaC complex endocytosis. 
Subsequently, activated AMPK stimulates protein kinase C (PKC)-ζ -mediated phosphorylation of 
the Na,K-ATPase α-subunit, leading to endocytosis of the transporter. Moreover, PKC-ζ activates 
JNK1/2, which phosphorylates LMO7b (the scaffolding protein) additionally promoting 
endocytosis of the Na,K-ATPase. Collectively, these signaling pathway downregulates both ENaC 
and Na,K-ATPase cell surface expression leading to inhibition of alveolar fluid clearance.  
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5.1 Hypercapnia inhibits transepithelial Na+ transport by promoting polyubiquitination of β- 
ENaC and endocytosis of the α/β-ENaC complex in alveolar epithelial cells 
Maintenance of low ALF volume by reabsorbing excess lung fluid is one of the primary functions 
of the alveolar epithelium and is a result of vectorial Na+ transport driven by ENaC and Na,K-
ATPase (Matthay et al. 2002; Mutlu and Sznajder 2005). It is well documented that patients with 
ARDS who cannot remove pulmonary edema efficiently have worse outcomes (Ware and Matthay 
2001). Importantly, CO2 retention is often detected in those patients and has been shown to impair 
alveolar fluid balance (Vadász et al. 2012; Vadász and Sznajder 2017). Of note, hypercapnia is an 
independent risk factor in critically ill patients and particularly in those with ARDS and is 
associated with higher mortality (Nin et al. 2017; Tiruvoipati et al. 2017).   
Here, we report that hypercapnia impairs plasma membrane stability of ENaC thereby reducing 
transepithelial Na+ transport. Functional ENaC is located at the apical surface of epithelial cells 
and endocytosis of the channel is one of the major mechanisms controlling ENaC activity and thus 
alveolar fluid clearance (Butterworth 2010; Eaton et al. 2010). Based on the previously observed 
impact of hypercapnia on Na,K-ATPase function (Vadász et al. 2008), we hypothesized that 
elevated CO2 levels may also affect functional expression of ENaC. Consistent with this 
hypothesis, our studies showed that elevated CO2 concentrations lead to a decrease in plasma 
membrane expression of the α/β-ENaC complex in primary rat ATII cells and in a human cell line. 
Importantly, the alterations in ENaC cell surface stability upon hypercapnia occurred without any 
obvious change in the intracellular levels of ENaC. The apparent lack of impact of short-term 
hypercapnia on total ENaC expression, suggests that an acute exposure to elevated CO2 
concentrations regulate the trafficking rather than the degradation of the channel. Similarly, 
intracellular levels of ENaC were not changed by short-term hypoxic exposure, as has been 
reported by Gille and co-workers (Gille et al. 2014). Moreover, no changes in ENaC mRNA levels 
upon hypercapnic exposure were detected when compared to normocapnic controls. Indeed, 
several pathogenic factors that are associated with ARDS, such as hypoxia (Wodopia et al. 2000), 
IL-4 (Galietta et al. 2002), TGF-β (Frank et al. 2003) or TNF-α (Dagenais et al. 2004) have been 
reported to modulate mRNA expression of ENaC. However, the effects of hypercapnia on ENaC 
transcription might depend on the duration of exposure to elevated CO2 concentrations. As has 
been reported in context of ENaC regulation by hypoxia and TGF-β, long-term exposure to low O2 
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concentrations or TGF-β impairs ENaC transcription and translation in AEC (Frank et al. 2003; 
Clerici and Plane 2009). In contrast, acute treatment with 1% O2 or TGF-β alters ENaC activity 
without changing mRNA expression (Gille et al. 2014; Peters et al. 2014). These observations 
correlate with our results, showing that hypercapnia causes only posttranslational modifications of 
ENaC over the short time frame (30 min) of treatment.  
It is well established that ENaC ubiquitination (a post translational modification) is one of the key 
pathways contributing to retrieval of the channel from the plasma membrane (Knight et al. 2006; 
Eaton et al. 2010; Rotin and Staub 2012). As we observed that hypercapnia increased ENaC 
retrieval from the plasma membrane of AECs, we next hypothesized that the alterations in the cell 
surface expression of the channel may be a consequence of elevated CO2-induced ubiquitination 
of ENaC. To test this hypothesis, we studied ubiquitination of ENaC α-, β-and γ-subunits upon a 
short (15 min) hypercapnic exposure. Results from these experiments showed an increased 
polyubiquitination of ENaC-β in response to elevated CO2 levels, whereas ubiquitination status of 
α- and γ-ENaC remained unaffected, thus suggesting differential sensitivity of the various channel 
subunits to hypercapnia. These data also indicate that the β-subunit of ENaC serves as a substrate 
of hypercapnia-induced ubiquitination. Of note, a numbers of studies show different ENaC 
ubiquitination patterns in response to different stimuli, reporting that α-, β- and γ-ENaC may be 
either multimono- or polyubiquitinated (Wiemuth et al. 2007; Zhou et al. 2007). These 
ubiquitination patterns of the various ENaC subunits subsequently promote endocytosis and/or 
degradation of the channel (Eaton et al. 2010). Whether one or more ENaC subunits undergo 
ubiquitination is dependent on the stimulus (Staub et al. 1997; Zhou et al. 2007; Rotin and Staub 
2012). While some stimuli target α-ENaC for ubiquitination (Staub et al. 1997; Hallows et al. 2010; 
Gille et al. 2014), others lead to ubiquitination of β-ENaC in which mutations of the PY recognition 
motif of SCNN1B gene prevent ubiquitination thus resulting in Na+ hyperabsorption (Abriel et al. 
1999; Malik et al. 2005). We observed that hypercapnia led to polyubiquitination of β-ENaC and 
subsequent endocytosis of the α/β-ENaC complex. This is in line with the well-known role of β-
ENaC regulating trafficking of the ENaC channel complex (Firsov et al. 1996).  
Acute lung injury is associated with impaired alveolar fluid clearance that contributes to persistence 
of pulmonary edema. Decreased fluid removal may be a consequence of reduced ENaC activity. 
Many pathogenic factors that are upregulated in the setting of ARDS contribute to a decreased 
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ENaC-driven Na+ transport and thus reabsorption of alveolar fluid. For example, TNF-α diminishes 
amiloride-sensitive current in ATII cells (Dagenais et al. 2004). Moreover, TNF-α also decreases 
expression of tight junction proteins, such as zonula occludens protein 1 thus increasing alveolar 
epithelial permeability leading to further accumulation of alveolar fluid (Wittekindt 2017). 
Interestingly, TNF-α has also been shown to activate ENaC via direct binding of the lectin-like 
domain of TNF, which can be mimicked by a so-called TIP peptide to α-ENaC. This binding 
rescues impaired ENaC activity in the presence of pneumococcal pneumolysin (PLY) (Czikora et 
al. 2014).  
Frank and colleagues reported reduced amiloride-sensitive Na+ transport in lung epithelial cells in 
response to TGF-β (Frank et al. 2003). In line with these observations, Peters and co-workers 
reported that TGF-β induced internalization of the β-ENaC from the alveolar epithelial cell surface 
leading to decreased AFC (Peters et al. 2014). Additionally, a negative impact of IL-1β on ENaC 
cell surface expression and amiloride-sensitive current has been shown in alveolar epithelial cells 
(Roux et al. 2005). These studies revealed that the inhibition of ENaC apical expression and activity 
occurs via p38 MAPK-dependent pathways. 
Hypercapnia is another factor frequently found in patients with ARDS (Vadász et al. 2012; Nin et 
al. 2017). The potentially negative and positive effects of elevated CO2 levels on the lungs and 
particularly in the setting of lung injury remain highly debated (Vadász et al. 2012). While earlier 
studies reported predominantly beneficial effects of hypercapnia on the lung, it appears that the 
potentially positive effects were rather a consequence of the acidosis that resulted from hypercapnia 
as opposed to the elevated CO2 levels per se (Higgins et al. 2009). More recently, it has been 
demonstrated in various species including rodents in vivo and human cells that elevated CO2 levels 
negatively affect the function of alveolar epithelium independently of pH. Several elements of the 
hypercapnia-induced signaling pathway have been described revealing that elevated CO2 
concentrations lead to activation of the metabolic sensor AMPK-α1 thereby promoting Na,K-
ATPase endocytosis via PKC-ζ-dependent phosphorylation of the Na,K-ATPase α-subunit (Briva 
et al. 2007; Vadász et al. 2008).  
A previous work focusing on the hypoxia-induced signaling pattern leading to a decrease in ENaC 
activity in rat AECs revealed a correlation between increased ubiquitination and decreased 
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amiloride-sensitive Na+ transport upon hypoxia (Gille et al. 2014). In contrast, Tan and co-workers 
demonstrated that an increased α-ENaC abundance at the apical membrane of H441 cells in 
response to apical fluid expansion is associated with augmented Na+ transport (Tan et al. 2011). 
These observations are in line with our results, demonstrating that elevated CO2 levels decrease 
total and amiloride-sensitive Na+ current as a consequence of ENaC endocytosis. Our cell surface 
protein labeling studies showed that hypercapnia decreases membrane abundance of ENaC and 
increases polyubiquitination of the β-subunit of the channel, thus providing insights into the 
molecular mechanisms involved in the CO2-induced Na
+ transport inhibition. Of note, the 
transepithelial resistance of cellular monolayers remained unaffected after hypercapnia, suggesting 
that the decrease in transepithelial Na+ current was not due to impaired cell viability or barrier 
integrity. However, as transepithelial vectorial Na+ transport is mediated by the concerted action 
of ENaC and Na,K-ATPase, the question remains, whether hypercapnia decreases amiloride-
sensitive Na+ transport solely due to direct inhibition of ENaC or indirectly as well, as a secondary 
effect of impaired Na,K-ATPase function. For example, Krause et al. demonstrated inhibited 
amiloride-sensitive Na+ absorption due to decreased Na,K-ATPase activity in H441 cell exposed 
to acute hypoxia (30 min) and H2S (Krause et al. 2016). The Na,K-ATPase generates the driving 
force for Na+ entry across the apical membrane, thus downregulation of ENaC may represent a 
cellular mechanism to prevent Na+ overload during stress conditions. Thus, it is possible (and 
indeed probable) that the hypercapnia-induced Na,K-ATPase dysfunction in turn also inhibits 
ENaC function. Further studies involving measurement of ouabain-sensitive Na+ current (mediated 
by Na,K-ATPase) are warranted to further tease out the relative contributions of direct and indirect 
effects of hypercapnia on ENaC function. The hypercapnia-induced downregulation of amiloride-
sensitive Na+-current may contribute to inhibition of AFC in hypercapnic patients with ARDS. 
While in most cases it is challenging to reduce hypercapnia without causing further lung injury or 
taking rather invasive measures such as extracorporeal membrane oxygenation, targeting the 
hypercapnia-induced signaling pathway which mediates ENaC downregulation may contribute to 
resolution of lung injury.  
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5.2 Elevated CO2 levels promote ENaC endocytosis by Nedd4-2-mediated ubiquitination of 
β-ENaC 
It is well established that binding of the E3 ligase, Nedd4-2 to the COOH-termini of the various 
ENaC subunits is prerequisite for ubiquitination of the channel and subsequent endocytosis and/or 
degradation (Abriel et al. 1999; Snyder et al. 2001; Lu et al. 2007; Kimura et al. 2011; Rotin and 
Staub 2012; Boase et al. 2011), although other E3 ligases may control ENaC trafficking in the 
lungs as well (Downs et al. 2013).  
Since our results showed a strong increase in β-ENaC ubiquitination upon hypercapnia, we 
hypothesized that Nedd4-2 may be implicated in the process of ENaC internalization. In line with 
this hypothesis, our experiments showed that genetic ablation of Nedd4-2 with a specific siRNA 
fully prevents β-ENaC polyubiquitination upon hypercapnic treatment. Moreover, hypercapnia-
induced redistribution of α/β-ENaC complex form the cell surface to intracellular stores was also 
reduced by Nedd4-2 knock-down. These findings are consistent with studies reported by Snyder 
and colleagues showing that Nedd4-2 silencing increased amiloride-sensitive Na+ current in H441 
cells (Snyder et al. 2004). Additionally, these authors also presented that a mutation in β-ENaC 
(R566X) associated with Liddle's syndrome blocks the effects of Nedd4-2 siRNA, further 
confirming the central role of Nedd4-2 in ENaC endocytosis. Moreover, our co-
immunoprecipitation data showed that β-ENaC and Nedd4-2 are assembled into a complex upon 
hypercapnia. Similarly, Malik et al. reported that Nedd4-2 was co-immunoprecipitated with α- and 
β-ENaC in A6 cells (Malik et al. 2005). In our studies, the association between these two proteins 
was detected also during normocapnic exposure, suggesting that Nedd4-2 plays role in ENaC 
turnover in both normal and pathological conditions. ENaC inhibition by hypoxia has been 
described as a result of Nedd4-2-driven ubiquitination and endocytosis (Gille et al. 2014). These 
observations are similar to our findings and may explain reduction in ENaC-driven Na+ transport 
upon acute hypercapnia treatment. Taken together, these data confirm contribution of Nedd4-2 in 
ENaC ubiquitination and internalization upon hypercapnic exposure.  
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5.3 Hypercapnia induces ENaC endocytosis by phosphorylation-dependent ubiquitination 
of ENaC β-subunit  
So far, our results showed that Nedd4-2 is a possible regulator of ENaC cell surface expression in 
the hypercapnic signaling cascade. Next, we set out to identify the molecular mechanisms by which 
Nedd4-2 mediates β-ENaC polyubiquitination upon elevated CO2. It has been previously shown 
that phosphorylation of target molecules may be required for initiation of ubiquitination probably 
by potentiating binding of the E3 ligase to the substrate (Butterworth et al. 2005; Hunter 2007). 
In mammals, at least 14 different MAPK signaling elements have been identified so far, categorized 
into 7 groups (Cargnello and Roux 2011). Our data suggest that the MAPK family member ERK1/2 
plays a central role in the hypercapnia-induced downregulation of ENaC. Several studies confirmed 
that ERK directly phosphorylates threonine residues located in the C-terminus of the β- and γ-
subunit of ENaC leading to enhanced docking of Nedd4-2 and thus causing ENaC internalization 
(Shi et al. 2002; Yang et al. 2006; Alli et al. 2012; Eaton et al. 2014). For example, Eaton and 
coworkers have reported that ERK activation inhibits ENaC via decreasing its cell surface density 
and Po in PKC-α knock-out mice in which elevated levels of ROS drive PKC-δ activation leading 
to decreased dephosphorylation of ERK, which in turn increases Nedd4-2-mediated ubiquitination 
and endocytosis of ENaC (Eaton et al. 2014). Moreover, an inhibition of amiloride-sensitive Na+ 
absorption driven by activation of ERK signaling has also been reported in murine collecting duct 
epithelial cells (mCT1) exposed to epithermal growth factor (EGF) (Shen and Cotton 2003). The 
relationship between increased activation of ERK and decreased levels of ENaC activity has also 
been documented in an in vitro study in rat ATII cells exposed to Cl2 in which reduced 
transepithelial Na+ transport was observed due to increased concentrations of reactive 
intermediates that mediated the phosphorylation of ERK. A similar inhibition of ENaC-driven Na+ 
transport was shown in lung slices of mice exposed to Cl2 (Lazrak et al. 2012). 
Based on these findings, we hypothesized that increased β-subunit polyubiquitination upon 
hypercapnia may be a consequence of higher ERK activity that drives β-ENaC phosphorylation 
leading to increased binding of Nedd4-2 to β-ENaC at the cell surface. Our experiments show that 
elevated CO2 concentrations promote rapid and time dependent ERK1/2 phosphorylation in A549 
cells. This is in line with previous studies reporting a comparable rapid and transient activation of 
ERK1/2 by elevated CO2 levels in rat ATII cells (Welch et al. 2010). Activation of ERK1/2 was 
Discussion 
 
86 
 
followed by phosphorylation of the T615 residue of β-ENaC similarly to what has been observed 
in a previous study (Shi et al. 2002). Moreover, treatment of cells with a specific inhibitor of ERK 
fully prevented polyubiquitination of β-ENaC and increased cell surface density of the α/β-ENaC 
complex upon hypercapnic exposure confirming a crucial role of active ERK in ENaC endocytosis. 
This is in line with the findings reported by Lazrak and co-workers, in which inhibition of 
amiloride-sensitive Na+ current resulted from decreased total levels of α-ENaC that was prevented 
by blocking ERK activity (Lazrak et al. 2012). 
A previous study has showed that mutations of T615 of β-ENaC and T623 of γ-ENaC to alanine 
prevents ERK-dependent phosphorylation and reduces channel endocytosis in Xenopus oocytes 
(Yang et al. 2006). These findings are in line with our results, in which the effect of hypercapnia-
induced ENaC retrieval form the cell surface was significantly reduced by deletion of the T615 
residue from the amino acid sequence of β-ENaC. Although we were unable to mutate T615 to A 
by site directed mutagenesis due to the high GC content present in the PY region of β-ENaC, 
deletion of this specific threonine confirmed that active ERK1/2 promotes ENaC retrieval from the 
plasma membrane via phosphorylation-dependent polyubiquitination of β-subunit. It is important 
to emphasize that deletion of this specific threonine from the β-ENaC sequence did not influence 
channel trafficking to the cell surface that was demonstrated by biotinylation experiments using 
cells overexpressing the β-ENaC mutant (ΔT615).  
5.4 JNK1/2-dependent phosphorylation of Nedd4-2 decreases cell surface abundance of α/β-
ENaC during hypercapnia 
Phosphorylation of Nedd4-2 is considered as an important mechanism for modulation of E3 ligase 
activity, representing an alternative way controlling ubiquitination of ENaC and other targets of 
the ligase (Bhalla et al. 2005). For example, PKA, SGK1 and with no lysine 1 (WNK1) have been 
reported to upregulate ENaC via inhibition of Nedd4-2 signaling (Snyder et al. 2004; Edinger et 
al. 2009; Xu et al. 2005). In contrast, active JNK1/2 (member of the MAPK family and an important 
regulator of cellular adaptation processes) activates Nedd4-2 thereby leading to ENaC 
downregulation (Hallows et al. 2010). Interestingly, JNK is crucial for elevated CO2-induced 
downregulation of the Na,K-ATPase (Vadász et al. 2012; Dada et al. 2015) and it has been recently 
reported that active JNK leads to phosphorylation of the S1295 residue of LMO7b allowing 
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interaction with Na,K-ATPase at the cell surface and thus promoting endocytosis of the transporter 
in AEC (Dada et al. 2015). Moreover, in the hypercapnia-induced Na,K-ATPase downregulation, 
the activation of JNK requires PKC-ζ-mediated phosphorylation at S129 (Vadász et al. 2012). In 
line with these previous findings regarding activation of JNK by hypercapnia in ATII cells (Vadász 
et al. 2012), our current data showed that JNK is strongly phosphorylated by elevated CO2 levels 
in A549 cells as well.  
A recent finding has shed light on the role of JNK1/2 in ENaC regulation. A stimulatory impact of 
JNK1 on Nedd4-2 activity has been described in polarized kidney epithelial cells and in Xenopus 
oocytes. These results showed that ubiquitination of α-ENaC required JNK1-driven 
phosphorylation of Nedd4-2 at the T899 residue, located in the HECT domain of the E3 ligase 
(Hallows et al. 2010). In agreement with that report, our data confirmed that mutation of T899 to 
alanine reduced ubiquitination of ENaC-β and restored normal cell surface density of the α/β-ENaC 
complex upon hypercapnia. Similarly, a rescued abundance of ENaC at the cell surface was 
observed after pretreatment of A549 cells with a specific JNK inhibitor. These results imply a 
crucial role of JNK in modulating Nedd4-2 activity and confirm that phosphorylation of Nedd4-2 
at the T899 residue is an important step in polyubiquitination of β-ENaC which is required for 
endocytosis of the α/β-ENaC in AEC in response to hypercapnia.  
5.5 Activity of AMPK-α1 is required for hypercapnia-induced ubiquitination and 
endocytosis of ENaC  
AMPK acts as cellular energy sensor and inhibits energy-consuming processes such as ion 
transport. This kinase has been described previously as an inhibitor of ENaC, the Na,K-ATPase 
and CFTR (Hallows et al. 2002; Vadász et al. 2008; Almaça et al. 2009). In agreement with these 
reports, our results demonstrate an important role of active AMPK in ENaC downregulation. We 
propose an elevated CO2-induced mechnism, in which ERK1/2 plays a dual role, namely, the 
kinase directly phoporylates β-ENaC at theT615 residue but also activates AMPK, which in turn 
promotes JNK1/2-mediated phoporylation of Nedd4-2, thereby leading to endocytosis of the α/β-
ENaC complex.  
Our data are in line with recently published observations showing that AMPK is an early element 
of the hypercapnic signaling cascade and that its activation appears to be downstream of ERK1/2 
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(Welch et al. 2010). Moreover, we showed that treatment of cells with a siRNA against AMPK-α1 
or a specific AMPK inhibitor markedly reduces elevated CO2-induced β-ENaC polyubiquitination 
and subsequent retrieval of the α/β-ENaC complex form the cell surface. Since ENaC endocytosis 
is dependent on Nedd4-2-mediated β-ENaC polyubiquitination upon hypercapnia, we 
hypothesized that AMPK regulates ENaC by controlling the Nedd4-2/ENaC-β interaction. 
Interestingly, enhanced expression of ENaC at the cell surface was reported in the distal airways 
in AMPK-α1−/− mice (Almaça et al. 2009). In those studies, AMPK inhibited ENaC by increasing 
its ubiquitination and subsequent endocytosis most likely due to enhancing Nedd4-2 activity. 
Bhalla and colleagues presented similar findings (Bhalla et al. 2006). In their studies AMPK-driven 
inhibition of ENaC by Nedd4-2 was prevented by overexpressing of a dominant-negative Nedd4-
2 mutant, confirming that Nedd4-2 is a required for AMPK-mediated ENaC downregulation. 
Moreover, the authors reported that AMPK activation enhanced β-ENaC/Nedd4-2 interaction in 
human embryonic kidney cells. This is consistent with our co-IP studies in A549 cells in which 
Nedd4-2 was co-immunoprecipitated with β-ENaC upon hypercapnia.  
In addition, CO2 has previously been described as a molecule that impacts intracellular Ca
2+ 
concentrations (Briva et al. 2007; Vadász et al. 2008). Of note, CaMKK-β senses alteration in 
intracellular calcium levels (Hawley et al. 2005) and has been identified as a key kinase activating 
AMPK-α1 in alveolar epithelial cells in response to hypercapnia and hypoxia (Vadász et al. 2008; 
Gusarova et al. 2011). These studies showed that active CaMKK-β drives AMPK-α1 
phosphorylation promoting Na,K-ATPase endocytosis by PKC-ζ-dependent phosphorylation of 
the Na,K-ATPase α-subunit at S18. In line with these findings, we demonstrated that pretreatment 
of A549 cells with a specific CaMKK-β inhibitor abolished the hypercapnia-induced effect of 
ENaC cell surface endocytosis by preventing AMPK activation. Similar inhibition of ENaC 
internalization in response to hypercapnia was obtained when A549 cells were pretreated with an 
ERK (upstream of AMPK) inhibitor. Taken together, these results suggest that the activation of 
AMPK is an essential step in the hypercapnia-induced ENC downregulation. Importantly, and 
confirming previously published data (Vadász et al. 2012), our current studies show that AMPK is 
upstream of JNK in the hypercapnic signaling pathway. Thus, it is most likely that the AMPK-
regulated impact on ENaC/Nedd4-2 interaction is mediated by JNK-dependent phosphorylation of 
Nedd4-2 at T899.  
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Collectively, our results demonstrate impaired ENaC cell surface abundance upon acute 
hypercapnia by Nedd4-2-driven polyubiquitination of ENaC-β and subsequent endocytosis of the 
α/β-ENaC complex as a result of a specific signaling pathway including activation of the 
ERK/AMPK/JNK axis. Interestingly, these kinases have previously been implicated as negative 
regulators of Na,K-ATPase (Gusarova et al. 2011; Dada et al. 2015; Vadász et al. 2012), suggesting 
that at least some key players of the hypercapnic signaling pathway may be common for regulation 
of both Na+ transporters. Thus, targeting elements of the CO2-induced deleterious signaling 
pathway may contribute to resolution of lung injury in hypercapnic patients with ARDS leading to 
better outcomes. 
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